<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2024.1494147</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Fate of <italic>in vitro</italic> cultured <italic>Mycobacterium abscessus</italic> populations when exposed to moxifloxacin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Salina</surname> <given-names>Elena G.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/663837/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Martini</surname> <given-names>Billy A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/819739/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sorokin</surname> <given-names>Vladimir V.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/936315/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mulyukin</surname> <given-names>Andrey L.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/422833/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff3"><sup>3</sup><institution>Winogradsky Institute of Microbiology, Research Center of Biotechnology of the Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: M. Nurul Islam, South Dakota State University, United States</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Martin I. Voskuil, University of Colorado Denver, United States</p>
<p>Basem Battah, Syrian Private University, Syria</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Elena G. Salina, <email>elenasalina@yandex.ru</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>11</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1494147</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Salina, Martini, Sorokin and Mulyukin.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Salina, Martini, Sorokin and Mulyukin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Given the current need for predictive persisting model for <italic>Mycobacterium abscessus</italic>, we adopted a classical assay to study drug-tolerant bacterial persisters, focusing on the behavior of a small antibiotic-insensitive subpopulation during prolonged exposure to moxifloxacin. Our study showed a wide-ranging response of <italic>M. abscessus</italic>, depending on antibiotic concentration, growth stage of mycobacterial cultures, and the availability of potassium ions in the medium. Mid-logarithmic cultures, initially grown in either balanced or K<sup>+</sup>-free medium, contained small sup-populations capable of prolonged and stable survival in the presence of moxifloxacin. The response of these mid-log cultures to antibiotic exposure involved initial killing, followed by regrowth at 1&#x2013;2 MBCs of moxifloxacin or a substantial reduction of the antibiotic-insensitive subpopulation to fewer than 10<sup>2</sup> CFU/mL at 16 MBCs. In stationary-phase cultures grown in a complete medium, a consistent number of viable cells was observed when exposed to a high dose of moxifloxacin. In contrast, antibiotic-insensitive subpopulations in stationary-phase <italic>M. abscessus</italic> cultures under potassium-deficient conditions experienced gradual killing across a wide range of moxifloxacin concentrations (1&#x2013;16 MBCs). Studies on electron microscopy demonstrated that singular cells were rapidly destroyed after relatively short-term exposure to moxifloxacin, while cells in aggregates or clumps persisted longer, explaining the delayed biocidal effect. The small subpopulation that survived under intense moxifloxacin pressure was notably heterogeneous in cell morphology and fine structure, consisting of ovoid forms and cell-wall-deficient cells with reduced size. These findings suggest that the same antibiotic dose may have varying effects on <italic>M. abscessus</italic> cells, depending on their physiological state and abundance within infected cells or tissues. Taken together, our study may contribute to the development of strategies to combat recalcitrant survivor subpopulations.</p>
</abstract>
<kwd-group>
<kwd><italic>Mycobacterium abscessus</italic></kwd>
<kwd>moxifloxacin</kwd>
<kwd>antimicrobials</kwd>
<kwd>bactericidal activity</kwd>
<kwd>survivors</kwd>
<kwd>drug insensitive subpopulation</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="74"/>
<page-count count="15"/>
<word-count count="10714"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Agents and Disease</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p><italic>Mycobacterium abscessus</italic> can cause severe lung, skin, soft tissue, and mucosal infections, whose incidences are constantly increasing, especially in patients with underlying respiratory diseases, particularly cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, and so on (<xref ref-type="bibr" rid="ref8">Bryant et al., 2021</xref>; <xref ref-type="bibr" rid="ref17">Degiacomi et al., 2019</xref>; <xref ref-type="bibr" rid="ref10">Cambau et al., 2024</xref>). <italic>M. abscessus</italic> is a critical target in the search for new drugs and treatment strategies, given its high resistance to most currently used antibiotics, including macrolides, aminoglycosides, rifamycins, tetracyclines, and &#x03B2;-lactams (<xref ref-type="bibr" rid="ref45">Nessar et al., 2012</xref>; <xref ref-type="bibr" rid="ref56">Recchia et al., 2023</xref>; <xref ref-type="bibr" rid="ref22">Fr&#x00F6;berg et al., 2023</xref>). The major role in the intrinsic resistance of mycobacteria to antimicrobial agents is played by the low permeability of the <italic>M. abscessus</italic> cell wall, nucleotide variants in genes coding for drug targets, numerous enzymes neutralizing antibiotics, a lack of drug-activating enzymes, induction of drug efflux pumps, and so on (<xref ref-type="bibr" rid="ref36">Luthra et al., 2018</xref>; <xref ref-type="bibr" rid="ref29">Johansen et al., 2020</xref>).</p>
<p>Extended antibiotic treatment may result in acquired drug resistance due to modifications of the genes encoding specific drug targets (<xref ref-type="bibr" rid="ref4">Bastian et al., 2011</xref>; <xref ref-type="bibr" rid="ref38">Maurer et al., 2012</xref>; <xref ref-type="bibr" rid="ref54">Prammananan et al., 1998</xref>).</p>
<p>Besides genetically determined mechanisms of resistance, there is another phenomenon of drug insusceptibility: nonheritable antibiotic tolerance or bacterial persistence. The phenomenon of bacterial persistence was first noticed in the 1940s upon experiments with penicillin, showing that 1% of pathogenic bacteria were found to survive after treatment (<xref ref-type="bibr" rid="ref27">Hobby et al., 1942</xref>). Later, Bigger, who studied this phenomenon in more detail, called a small number of staphylococci that survived exposure to penicillin &#x201C;persisters&#x201D; (<xref ref-type="bibr" rid="ref7">Bigger, 1944</xref>). Persister cells are a small subpopulation that can withstand lethal concentrations of bactericidal antibiotics without developing resistance (<xref ref-type="bibr" rid="ref2">Balaban et al., 2019</xref>; <xref ref-type="bibr" rid="ref46">Newson et al., 2022</xref>) and emerge upon antibiotic withdrawal, causing the resumption of infection (<xref ref-type="bibr" rid="ref64">Swaminath et al., 2020</xref>; <xref ref-type="bibr" rid="ref33">Lewis, 2007</xref>). Notably, persisters isolated from an infected animal retain their virulence upon reinfection (<xref ref-type="bibr" rid="ref46">Newson et al., 2022</xref>). Moreover, phenotypic heterogeneity of bacterial populations with the presence of a subpopulation of drug-tolerant persisters is recognized as one of the virulence strategies of the pathogen (<xref ref-type="bibr" rid="ref68">Weigel and Dersch, 2018</xref>; <xref ref-type="bibr" rid="ref46">Newson et al., 2022</xref>; <xref ref-type="bibr" rid="ref61">Shang et al., 2020</xref>).</p>
<p>Drug-tolerant persisters, irrespective of broad or traditional definitions of the persistence phenomenon (<xref ref-type="bibr" rid="ref2">Balaban et al., 2019</xref>; <xref ref-type="bibr" rid="ref23">Gold and Nathan, 2017</xref>), are recognized targets in the discovery of potent drugs against various pathogenic bacteria (<xref ref-type="bibr" rid="ref33">Lewis, 2007</xref>; <xref ref-type="bibr" rid="ref67">Wainwright et al., 2021</xref>; <xref ref-type="bibr" rid="ref50">Niu et al., 2024</xref>; <xref ref-type="bibr" rid="ref34">Lewis, 2012</xref>). As with <italic>M. abscessus</italic>, the emerging and resistant pathogen that has attracted great attention in repurposing the existing and discovery of new antimicrobial agents (<xref ref-type="bibr" rid="ref47">Nguyen et al., 2024</xref>), it is currently topical to adopt and implement persister-specific assays (<xref ref-type="bibr" rid="ref70">Wu et al., 2018</xref>). While the phenomenon of bacterial persistence is well-studied, the antibiotic persistence of the emerging pathogen <italic>M. abscessus</italic> remains poorly understood. Non-growing starved cells in phosphate buffer were used in addition to conventionally tested planktonic cells in aerated rich medium (<xref ref-type="bibr" rid="ref6">Berube et al., 2018</xref>). The most comprehensive assay encompassed biofilms, non-replicating cells in nutrient-starved or anaerobic cultures for MIC and MBC determinations (<xref ref-type="bibr" rid="ref71">Yam et al., 2020</xref>). In this study, we employed the classical methodology and approaches used for the other bacteria (<xref ref-type="bibr" rid="ref3">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="ref30">Keren et al., 2004</xref>; <xref ref-type="bibr" rid="ref33">Lewis, 2007</xref>) with a focus on a typically small drug-insensitive subpopulation in mid-logarithmic and stationary-phase <italic>M. abscessus</italic> cultures that could survive and resume growth after antibiotic withdrawal.</p>
<p>We hypothesize that <italic>M. abscessus</italic> response to antibiotics depends on the growth stage, the medium composition, the concentration of an antimicrobial agent, and a relatively stable growth-arrest state that occurs under certain experimental conditions. The bi- or triphasic response to prolonged exposure to antibiotics, involving the successive killing, persistence, and regrowth stages, has been known for the other mycobacteria&#x2014;<italic>M. tuberculosis</italic> and <italic>M. smegmatis</italic> (<xref ref-type="bibr" rid="ref60">Sebastian et al., 2017</xref>; <xref ref-type="bibr" rid="ref64">Swaminath et al., 2020</xref>) and is expected for <italic>M. abscessus</italic>. Since susceptibilities of <italic>M. abscessus</italic> to antimicrobials varied greatly for aerated, stressed, hypoxic cultures (<xref ref-type="bibr" rid="ref71">Yam et al., 2020</xref>), it is impossible to predict the behavior of a subpopulation developing under different growth and nutritional conditions and left viable after killing the antibiotic-sensitive majority. Using viability tests and a combination of electron microscopy methods, we show that the fate of <italic>M. abscessus</italic> under prolonged exposure to moxifloxacin, a recommended antibiotic, is conditional upon the physiological state of cultures prior to the antibiotic challenge. For this study, we specifically selected potassium deficiency in the growth media as a stress condition, which promotes the transition of cultures to a metabolically inactive state with a significant loss of colony-forming ability, as shown for <italic>M. abscessus</italic> (<xref ref-type="bibr" rid="ref41">Mulyukin et al., 2023</xref>) and <italic>M. tuberculosis</italic> (<xref ref-type="bibr" rid="ref57">Salina et al., 2014a</xref>,<xref ref-type="bibr" rid="ref58">b</xref>).</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Bacterium and media</title>
<p><italic>Mycobacterium abscessus</italic> ATCC 19977<sup>T</sup> was provided by the European Polytechnic School of Lausanne (Lausanne, Switzerland) and stored at &#x2212;70&#x00B0;C. Starter cultures were initially grown from frozen stocks in 7H9 (Himedia, India) with 10% ADS (0.5% BSA, 0.2% dextrose, 0.085% sodium chloride) and 0.05% Tween-80 (Neofroxx GmbH, Germany) at 37&#x00B0;C with shaking at 200&#x202F;rpm for 3&#x202F;days. A starter culture was inoculated (0.25%) into Sauton medium, containing: KH<sub>2</sub>PO<sub>4</sub>, 0.5&#x202F;g; MgSO<sub>4</sub>&#x00B7;7H<sub>2</sub>O, 1.4&#x202F;g; L-asparagine, 4&#x202F;g; glycerol, 60&#x202F;mL; ferric ammonium citrate, 0.05&#x202F;g; sodium citrate, 2&#x202F;g; 1% ZnSO<sub>4</sub> &#x00B7; 7H<sub>2</sub>O, 0.1&#x202F;mL; H<sub>2</sub>O, to 1&#x202F;L; pH 7.0 (adjusted with 1&#x202F;M NaOH) or into potassium-free Sauton media with ADS and Tween-80 in which K<sup>+</sup> ions (3.7&#x202F;mM) were equimolarly substituted for Na<sup>+</sup> ions (<xref ref-type="bibr" rid="ref57">Salina et al., 2014a</xref>,<xref ref-type="bibr" rid="ref58">b</xref>) with the addition of 10% ADS and 0.05% Tween-80. Cultures were incubated in loose-capped flasks at 37&#x00B0;C with shaking at 200&#x202F;rpm for 3&#x202F;days to the mid-log phase or 10&#x2013;14&#x202F;days to the stationary phase.</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Minimum inhibitory concentration</title>
<p>Determination of antibiotic MICs using the resazurin reduction microplate assay (REMA) was performed as previously described (<xref ref-type="bibr" rid="ref52">Palomino et al., 2002</xref>). Briefly, a series of consequential twofold dilutions of amikacin, bedaquiline, ciprofloxacin, clofazimine, linezolid, moxifloxacin, or rifampicin in Sauton medium with 10% ADS was added with 100-&#x03BC;l aliquots to wells in Corning plates (Corning, USA) in the concentration range from 64 to 0.5&#x202F;&#x03BC;g/mL. Middle-logarithmic <italic>M. abscessus</italic> cultures in Sauton medium were diluted with fresh medium to 2&#x02D1;10<sup>5</sup> CFU/mL and then added in 100-&#x03BC;L portions to each well with and without antibiotics (control) to final 200-&#x03BC;L volumes and 1&#x02D1;10<sup>5</sup> CFU/mL. After incubation of the plates for 24&#x202F;h at 37&#x00B0;C, resazurin (Merck, Germany) was added to wells at the concentration of 0.025&#x202F;mg/mL. Following overnight incubation at 37&#x00B0;C, the fluorescence of resorufin, the resazurin metabolite, was measured using a Fluostar Omega microplate reader (BMG-Labtech, Germany) at the excitation and emission wavelengths of 544&#x202F;nm and 590&#x202F;nm, respectively. The MIC was defined as the lowest concentration that prevented resazurin from turning blue to pink, based on both visual observation and fluorescence measurements (<xref ref-type="bibr" rid="ref32">Lechartier et al., 2012</xref>).</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Bactericidal effect</title>
<p><italic>Mycobacterium abscessus</italic> cells were grown in Sauton medium to either the mid-log or stationary phase (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>), sampled into sterile Falcon tubes (Corning, USA), and pelleted by centrifugation at 3000&#x202F;&#x00D7;&#x202F;<italic>g</italic> for 15&#x202F;min. The supernatants from each culture were transferred to separate tubes. Pelleted mid-log cells were resuspended using the supernatant from mid-log phase cultures, while stationary-phase cells were resuspended with the supernatant from stationary-phase cultures. Fresh Sauton medium or buffer was not used to prevent further growth or starvation stress.</p>
<p>Suspensions were adjusted to a cell density of OD<sub>600</sub>&#x202F;=&#x202F;0.1, agitated at 100&#x202F;rpm at 37&#x00B0;C for approximately 4&#x202F;h (a period shorter than the mean generation time of 5&#x202F;h), and treated with 31, 63, 125, 250, and 500&#x202F;&#x03BC;g/mL of moxifloxacin (Merck, Germany). The cultures were incubated for 1, 3, 7, and 14&#x202F;days (at 37&#x00B0;C with agitation at 100&#x202F;rpm). Mid-log cultures were further diluted with the corresponding supernatant to OD<sub>600</sub>&#x202F;=&#x202F;0.001 (~5 &#x02D1;10<sup>5</sup> CFU/mL) and OD<sub>600</sub>&#x202F;=&#x202F;0.00001 (~5 &#x02D1;10<sup>3</sup> CFU/mL) and exposed to 4 and 10&#x202F;&#x03BC;g/mL of moxifloxacin for 1, 2, 3, 5, and 7&#x202F;days (at 37&#x00B0;C with agitation at 100&#x202F;rpm).</p>
<p>After antibiotic treatment, cultures were washed with fresh Sauton or potassium-free Sauton media supplemented with ADS and Tween-80 to remove residual antibiotics. Then, the bactericidal effect was evaluated using CFU and MPN assays.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Viability tests</title>
<p>Tenfold serially diluted cell suspensions were plated in triplicates onto 7H10 agar plates (Himedia, India) supplemented with 10% ADS in <italic>Petri dishes</italic> and incubated at 37&#x00B0;C for 6&#x202F;days, followed by CFU counting. The bactericidal effect was also evaluated using the most probable number (MPN) method to account for cells that had lost the ability to form CFU on agar plates but could still grow in a liquid medium. For the MPN assays, the same tenfold serial dilutions were inoculated into diluted liquid Sauton medium (1:1 [vol/vol]; final concentration of glycerol, 0.6%) (<xref ref-type="bibr" rid="ref57">Salina et al., 2014a</xref>,<xref ref-type="bibr" rid="ref58">b</xref>), supplemented with 10% ADS, in 96-well Corning plates. The plates were left to stand at 37&#x00B0;C for 8&#x2013;10&#x202F;days. Wells with visible bacterial growth were counted as positive, and MPN values were calculated with 95% confidence limits using statistical tables designed based on probability histograms (<xref ref-type="bibr" rid="ref15">de Man, 1975</xref>). MPN values were calculated by counting wells with visible turbidity for a series of at least five serial tenfold dilutions prepared in triplicate. The exact confidence limits, with a minimal probability of 95%, for each MPN value were obtained from the corresponding statistical tables (<xref ref-type="bibr" rid="ref15">de Man, 1975</xref>).</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Transmission electron microscopy (TEM)</title>
<p>Cells from 10-mL cultures were harvested upon pelleting down at 4000&#x202F;<italic>g</italic> for 10&#x202F;min and washed twice in sterile mQ water with further centrifugation. Then, cells were fixed in 2.5% glutaraldehyde (w/v) in 0.1&#x202F;M sodium cacodylate buffer (pH 7.2) for 2.5&#x202F;h, pelleted, and then post-fixed in 1% (w/v) osmium tetroxide in the same buffer for 12&#x202F;h. The osmium fixative was removed upon centrifugation, and a heated sterile water solution with agar (2%) was added dropwise to the residue and allowed to stay for solidification. The agar-embedded material was cut into millimeter-sized pieces and dehydrated in 3% uranyl acetate in 30% ethanol for 2&#x202F;h and 70% ethanol for 12&#x202F;h with further 10-min changes in a series: 96% ethanol (twice); 96%-acetone (1: 1&#x202F;v/v) and acetone (trice). Dehydrated specimens were soaked with epoxy resin Epon 812 (Fluka, Switzerland) with the components&#x2014;acetone mixtures (1:1 and 1:2&#x202F;v/v)&#x2014;and placed in capsules with the resin (without acetone) for polymerization at 40&#x00B0;C for 24&#x202F;h and then 60&#x00B0;C for 24&#x202F;h. The produced blocks were trimmed across visible sediment using an 8,800 Ultrotome III (LKB-Produkter, Sweden) to prepare thin sections. Sections were placed on copper grids (Jeol, Tokyo, Japan) coated with Formvar and stained with aqueous 3% uranyl acetate and then 3.5% lead citrate for 20&#x202F;min at 37&#x00B0;C, and air-dried for 24&#x202F;h. Specimens were examined under a JEM-1400 electron microscope (Jeol, Japan) operating at 80&#x202F;kV.</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>Scanning electron microscopy (SEM)</title>
<p>Starting and 10-fold diluted suspensions of cells after washing in mQ water were dropped on cleaned coverslip pieces mounted on SEM specimen stubs. After drying in the air for 12&#x202F;h in Perti dishes, the samples were coated with Au in a JFC-1100 ion sputter (Jeol, Tokyo, Japan). Specimens were examined under a JSM-IT200 electron microscope (Jeol, Japan).</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Energy dispersive X-ray spectroscopy (EDX)</title>
<p>Harvested cells were washed from the medium with distilled water, re-suspended in different dilutions, and dropped with 5&#x2013;10-&#x03BC;L aliquots on Formvar-coated and carbon-reinforced copper grids and air-dried for 12&#x202F;h (Washing of cells was necessary to prevent film formation from medium components; fixatives were inadmissible to alter the elemental composition). Specimens were subjected to EDX spectroscopy analysis under TEM mode with recording of total images and mapping of elements using a JEM-1400 microscope (Jeol, Japan) equipped with an energy-dispersive X-ray analysis system (EDXA, Inca Energy-350, Oxford Instruments, UK), operating at an accelerating voltage of 80&#x202F;keV (tilt angle, 15&#x00B0;). The examination procedure involved choosing a TEM image and EDX spectroscopy to detect all chemical elements in the entire image or the region of interest with mapping of all or optionally selected elements using Aztec software (Oxford Instruments, UK). A map for each element was automatically marked with different colors for visual representation. Electron microscopy studies were performed in the UNIQEM Collection Core Facility.</p>
</sec>
<sec id="sec10">
<label>2.8</label>
<title>Analysis of SEM and TEM images</title>
<p>Suitable SEM and TEM images were used for morphometric analysis to estimate quantitatively the heterogeneity of populations in the cell size and morphological types in control or experimental groups. We examined SEM micrographs and distinguished between individual cells with intact, destructed, thinned, and smoothened surfaces, counted their numbers, and calculated their proportions. The mean length and width of intact were measured on TEM images of longitudinal thin sections. Suitable transverse sections across the long axis were also used to calculate the mean width; &#x2018;empty&#x2019; sections were excluded from the analysis. Cells were referred to the N category (as those in the corresponding control group) if their dimensions were close to 1.70&#x202F;&#x00B1;&#x202F;0.36 &#x03BC;m&#x202F;&#x00D7;&#x202F;0.34 &#x00B1;&#x202F;0.07 &#x03BC;m (L&#x202F;&#x00D7;&#x202F;W); cells with more than twice shorter length and/or width were referred to the reduced size category (R category). Upon examinations of TEM images, we ascribed individual cells to a particular morphological type and evaluated their occurrence relative to the numbers of all or intact cells. TEM and corresponding EDX spectral maps were pairwise compared to confirm the presence/absence of elements in cells viewed on TEM images. In particular, cells on TEM images were grouped into clumps (aggregates) and singular cells and then into potassium-containing and free subgroups.</p>
</sec>
<sec id="sec11">
<label>2.9</label>
<title>Statistics</title>
<p>Experiments were conducted in at least two biological and three technical replications. Statistical analysis was performed using Microsoft<sup>&#x00AE;</sup> Office<sup>&#x00AE;</sup> Excel 2016 MSO (16.0.4639.1000). The data were expressed as the mean&#x202F;&#x00B1;&#x202F;standard deviation. Data were analyzed using Student&#x2019;s unpaired <italic>t</italic>-test; a <italic>p-</italic>value of &#x003C; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="sec12">
<label>3</label>
<title>Results</title>
<sec id="sec13">
<label>3.1</label>
<title>Insufficient killing activity of moxifloxacin at 2 and 5 MICs against <italic>Mycobacterium abscessus</italic></title>
<p>Traditionally, the minimum inhibitory concentration (MIC) is defined as the lowest drug concentration that prevents a bacterial suspension of 1&#x02D1;10<sup>5</sup>&#x2013;5 &#x02D1;10<sup>5</sup> CFU/mL from becoming turbid after a defined incubation period. The minimum bactericidal concentration (MBC) is determined as the lowest drug concentration that reduces the bacterial population with 1&#x02D1;10<sup>5</sup>&#x2013;5&#x02D1;10<sup>5</sup> CFU/mL to 1&#x02D1;10<sup>2</sup>&#x2013;5&#x02D1;10<sup>2</sup> CFU/mL during the incubation period, but it has been proposed to lower this threshold to 99.0% for slowly growing mycobacteria (<xref ref-type="bibr" rid="ref37">Maurer et al., 2014</xref>; <xref ref-type="bibr" rid="ref24">Greendyke and Byrd, 2008</xref>). We used different initial concentrations of cells for primary assays of moxifloxacin activity against <italic>M. abscessus</italic> for the following reasons.</p>
<p>In addition to the previously initial cell densities, a starting concentration of 5 &#x02D1;10<sup>7</sup> CFU/mL was used because the residual subpopulation after moxifloxacin exposure could not be reliably quantified using CFU assays at lower densities (5 &#x02D1;10<sup>5</sup> CFU/mL) Suspensions with 5 &#x02D1;10<sup>3</sup> CFU/mL were used to assess responses to moxifloxacin, considering that mycobacteria may exist in microenvironments with low cell densities.</p>
<p>For this study, MIC determinations for amikacin, bedaquiline, ciprofloxacin, clofazimine, linezolid, moxifloxacin, and rifampicin were conducted using the microtiter rezazurin assay (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Bedaquiline and moxifloxacin with MICs of 2&#x202F;&#x03BC;g/mL appeared to be the most active among the rest of the antibiotics (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Unlike bedaquiline, moxifloxacin exerted activity against both actively growing and &#x2018;non-culturable&#x2019; metabolically inert <italic>M. abscessus</italic> cells (<xref ref-type="bibr" rid="ref41">Mulyukin et al., 2023</xref>) and was chosen for further experiments reported below. The MBC of moxifloxacin exceeded 5 MICs (10&#x202F;&#x03BC;g/mL), as found from killing curves for cell suspensions at the same cell density of ~5&#x02D1;10<sup>5</sup> CFU/mL. In this case, treatment with 2 and 5 MICs of moxifloxacin resulted in a decrease of CFU numbers (&#x003C;2 log<sub>10</sub> units/day) with the subsequent regrowth to the cell numbers as in the control antibiotic-free culture (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>M. abscessus</italic> suspensions that were adjusted to a low density (~5&#x02D1;10<sup>3</sup> CFU/mL) upon dilution with the collected cell-free supernatant displayed a similar response, and the MBC was higher than 10&#x202F;&#x03BC;g/mL (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Subsequent experiments excluded suspensions with 10<sup>3</sup>&#x2013;10<sup>5</sup> CFU/mL of <italic>M. abscessus</italic>, as the small fractions of surviving cells were not reliably detectable using CFU assays.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Numbers of viable cells (CFU/mL) in <italic>M. abscessus</italic> suspensions grown to the mid-logarithmic phase, diluted with the collected supernatant to various cell densities, and incubated in the absence or the presence of moxifloxacin added at concentrations of 4 and 10&#x202F;&#x03BC;g/mL (2 and 5 MICs, respectively). <bold>(A)</bold> Initial cell density&#x202F;~&#x202F;5&#x02D1;10<sup>3</sup> CFU/mL. <bold>(B)</bold> Initial cell density&#x202F;~&#x202F;5&#x02D1;10<sup>5</sup> CFU/mL (as in conventional assays for MBC). <bold>(C)</bold> Initial cell density&#x202F;~&#x202F;5&#x02D1;10<sup>7</sup> CFU/mL. The experiments were performed independently twice in triplicates; the mean values and standard deviations are shown here: &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, unpaired <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g001.tif"/>
</fig>
<p>Mid-log <italic>M. abscessus</italic> cells at the elevated cell density of ~5&#x02D1;10<sup>7</sup> CFU/mL (OD<sub>600</sub>&#x202F;=&#x202F;0.1) responded to 5 MICs of moxifloxacin (10&#x202F;&#x03BC;g/mL) with a 60% reduction in the CFU numbers within 24&#x202F;h followed by the regrowth during the next 6&#x202F;days (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Two MICs (4&#x202F;&#x03BC;g/mL) of moxifloxacin caused a bacteriostatic effect, as seen from unchanged CFU numbers over 24&#x202F;h, which was followed by regrowth to the cell density as in control antibiotic-free cultures (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). It is noteworthy that exposure to moxifloxacin (2 or 5 MICs) for 24&#x202F;h was insufficient to abolish antibiotic-sensitive subpopulations. Regarding the relatively slow and incomplete or inefficient killing of active <italic>M. abscessus</italic> cells upon exposure to moxifloxacin in several MICs (<xref ref-type="fig" rid="fig1">Figure 1</xref>), we extended the antibiotic concentration range to reveal low-abundant surviving fractions.</p>
</sec>
<sec id="sec14">
<label>3.2</label>
<title>The MBCs of moxifloxacin for <italic>Mycobacterium abscessus</italic> grown in complete or potassium-free Sauton media</title>
<p>The M&#x0412;&#x0421; for mid-log <italic>M. abscessus</italic> cultures (initial density&#x202F;~&#x202F;5&#x02D1;10<sup>7</sup> CFU/mL; OD<sub>600</sub>&#x202F;=&#x202F;0.1) grown in each medium (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>) was 31&#x202F;&#x03BC;g/mL, as determined by CFU counts (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2A,C</xref>). Similarly, the MBC after 3&#x202F;days of exposure to moxifloxacin for stationary-phase <italic>M. abscessus</italic> cells (initial density&#x202F;~&#x202F;5&#x02D1;10<sup>7</sup> CFU/mL; OD<sub>600</sub>&#x202F;=&#x202F;0.1) grown in either complete or potassium-free medium (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>) was also 31&#x202F;&#x03BC;g/mL (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 3A,C</xref>). However, the bactericidal effect, indicated by a CFU reduction of more than 2 log<sub>10</sub> units, varied in duration depending on the medium used for cultivation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2, 3</xref>).</p>
<p>Since CFU-based assays alone may overestimate antibacterial efficacy, as observed with <italic>M. abscessus</italic> (<xref ref-type="bibr" rid="ref41">Mulyukin et al., 2023</xref>), the most probable number (MPN) test was also used to estimate viable bacteria counts following treatment with moxifloxacin at concentrations well above the MBC. However, both MPN-and CFU-based assays yielded similar numbers of viable cells in both moxifloxacin-free and treated cultures (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2B,D, 3B,D</xref>), indicating a bactericidal effect rather than the induction of &#x201C;non-culturability&#x201D; in the presence of this antibiotic. For pairwise comparisons, we selected groups with statistically significant differences (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05) from the control and other experimental groups. The original data sets (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2, 3</xref>) were transformed into the plots shown in <xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Response of <italic>M. abscessus</italic> cultures grown to the mid-logarithmic phase to increasing over-MBC moxifloxacin concentrations. The graphs show the corresponding groups with statistically significant differences (<italic>p</italic> &#x003C;&#x202F;0.05). <bold>(A,B)</bold> The CFU/ml changes for cultures grown in the complete or potassium-free Sauton media, respectively.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g002.tif"/>
</fig>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Contrast response of <italic>M. abscessus</italic> cultures grown to the stationary phase to increasing over-MBC moxifloxacin concentrations. The graphs show the corresponding groups with statistically significant differences (<italic>p</italic> &#x003C;&#x202F;0.05). <bold>(A,B)</bold> The CFU/mL changes for cultures grown in the complete or potassium-free Sauton media, respectively.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g003.tif"/>
</fig>
</sec>
<sec id="sec15">
<label>3.3</label>
<title>Response of mid-log <italic>Mycobacterium abscessus</italic> cells to moxifloxacin</title>
<p>Treatment of suspensions with 5&#x02D1;10<sup>7</sup> CFU/mL (OD<sub>600</sub>&#x202F;=&#x202F;0.1) from actively growing cultures in complete Sauton medium with increasing over-MBC moxifloxacin concentrations caused a profound killing effect (1.13&#x202F;&#x00B1;&#x202F;0.01, 1.34&#x202F;&#x00B1;&#x202F;0.02, and 1.40&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/days for concentrations 31&#x2013;62, 125&#x2013;250, and 500&#x202F;&#x03BC;g/mL, respectively) within 3&#x202F;days (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The subsequent regrowth of surviving subpopulations was dependent upon the concentration of moxifloxacin. As for treatments with 1&#x2013;2 MBCs (31 and 62&#x202F;&#x03BC;g/mL), the regrowth started from day 3 with the rate of 0.50&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day, yielding the cell numbers by day 14 as in the control antibiotic-free cultures (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The response to exposure to 4&#x2013;8 MICs of moxifloxacin involved an intermediate stage (days 3 to 7) when insensitive subpopulations were killed at a lower rate (0.18&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day) than the susceptible subpopulation (1.34 log<sub>10</sub> units). The number of viable cells declined insignificantly, within one order of magnitude (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This intermediate stage was followed by slow regrowth (at a rate of 0.29&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day) as in the case of treatments with 4&#x2013;8 MBCs (125&#x2013;250&#x202F;&#x03BC;g/mL). The highest moxifloxacin concentration (16 MBCs, 500&#x202F;&#x03BC;g/mL) prevented the regrowth (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In addition, we performed the following assay. Colonies on agar medium upon plating of survived cells (7&#x202F;days after treatment with 8 MBCs of moxifloxacin) were inoculated to fresh Sauton broth, grown to the mid-log phase, and subjected to the same antibiotic treatment according to the guides (<xref ref-type="bibr" rid="ref2">Balaban et al., 2019</xref>). CFU assays showed no substantial increase in the size of survivors after the second round of exposure to moxifloxacin.</p>
<p><italic>Mycobacterium abscessus</italic> cells that were grown to the mid-log phase in a potassium-free Sauton medium displayed a similar response upon exposure to moxifloxacin as in the case of the complete medium (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The major statistically significant difference (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05) in the behavior of survived subpopulations in these media was the faster regrowth (0.49&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day) starting from day 7 and yielding the higher numbers of cells (10<sup>7</sup>&#x202F;CFU/mL, <xref ref-type="fig" rid="fig2">Figure 2B</xref>) as with K<sup>+</sup> depletion than for cells in the complete medium (regrowth at 0.29 logs/day to 10<sup>5</sup>&#x202F;CFU/mL, days 7 to 14, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) for the exposures to 4&#x2013;8 MBCs of moxifloxacin. The highest moxifloxacin dose (16 MBCs, 500&#x202F;&#x03BC;g/mL) was sufficient to cause severe killing of an antibiotic-insensitive subpopulation pre-formed in K<sup>+</sup> free medium to a residual level of 10<sup>2</sup>&#x202F;CFU/mL by day 14 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
</sec>
<sec id="sec16">
<label>3.4</label>
<title>Response of stationary-phase <italic>Mycobacterium abscessus</italic> cells to moxifloxacin</title>
<p>Before treatment with moxifloxacin, stationary-phase <italic>M. abscessus</italic> cultures (12&#x2013;14&#x202F;days) were diluted to OD<sub>600</sub>&#x202F;=&#x202F;0.1 with the spent medium in which cells grew. After the challenge of stationary cells in the complete Sauton medium to moxifloxacin 1&#x2013;8 MBCs, we observed a gradual decrease (0.23&#x202F;&#x00B1;&#x202F;0.01&#x2013;0.47&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day) in the viable cell numbers during 7&#x202F;days and then regrowth (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). A stable stage with unchanged numbers of viable cells (1&#x2013;3&#x00B7;10<sup>4</sup>&#x202F;CFU/mL) was observed for stationary-phase cultures grown in the complete medium and exposed to 500&#x202F;&#x03BC;g/mL of moxifloxacin (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p>
<p>In contrast, antibiotic-insensitive subpopulations in stationary-phase <italic>M. abscessus</italic> cultures under potassium deficiency experienced gradual killing (0.31&#x202F;&#x00B1;&#x202F;0.01&#x2013;0.61&#x202F;&#x00B1;&#x202F;0.01 log<sub>10</sub> units/day) during exposure to moxifloxacin across a wide concentration range (1&#x2013;16 MBCs) with no subsequent regrowth (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). By day 14, the residual number of viable cells was approximately 1&#x00B7;10<sup>2</sup>&#x202F;CFU/mL (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Thus, the behavior of a pre-formed fraction of survivors in stationary-phase cultures exposed to moxifloxacin is dependent on the availability of potassium ions in the growth medium.</p>
</sec>
<sec id="sec17">
<label>3.5</label>
<title>Enumeration of antibiotic-insensitive surviving fractions</title>
<p>To enumerate <italic>M. abscessus</italic> survivors that remained viable during exposure to moxifloxacin, we followed established guidelines for measuring persisters, defined as a small subpopulation of bacteria that are killed by antibiotics at a slower rate than the susceptible population. The size of this subpopulation shows a weak dependence on concentration, resulting in a biphasic killing curve (<xref ref-type="bibr" rid="ref2">Balaban et al., 2019</xref>).</p>
<p>Both killing curves, &#x201C;CFU&#x2013;time&#x201D; for varying concentrations of moxifloxacin (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2, 3</xref>) and &#x201C;CFU&#x2013;concentration&#x201D; at a selected time point after antibiotic treatment, were analyzed (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>). As the elimination of moxifloxacin-sensitive cells occurred within 3&#x202F;days of exposure, dose-killing assay results were considered for this time frame.</p>
<p>As for mid-logarithmic and stationary-phase <italic>M. abscessus</italic> cultures in complete Sauton medium, the killing effect was not dependent substantially upon the concentration of the antibiotic starting from 63 to 500&#x202F;&#x03BC;g/mL as the CFU numbers reached a plateau or changed insignificantly (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>). According to the mean viable cell numbers at the plateau level, the percentage of survivors was estimated as being 0.03% (1.2&#x00B7;10<sup>4</sup>&#x202F;CFU/mL) and 0.72% (7.5&#x00B7;10<sup>5</sup>&#x202F;CFU/mL) of the CFU before the antibiotic treatment for mid-log and stationary cultures, respectively (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The fractions of survivors that remained viable after exposure to moxifloxacin constituted 0.02% (8.1&#x00B7;10<sup>3</sup>&#x202F;CFU/mL) and 0.62% (9.8&#x00B7;10<sup>5</sup>&#x202F;CFU/mL), respectively, for mid-log and stationary cultures grown in K<sup>+</sup>-free medium, respectively, as with the complete Sauton medium (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>The percentage of survivors in mid-logarithmic and stationary-phase <italic>M. abscessus</italic> cultures grown in complete and potassium-free Sauton medium was estimated upon counting viable cells using CFU and MPN assays. Cultures were exposed to 2&#x2013;16 MBCs of moxifloxacin and incubated for 3&#x202F;days. Dose-kill curves for this time point are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>. The percentage of survivors was determined from the residual CFU/mL and MPN/mL numbers normalized for the numbers of viable cells prior to exposure to moxifloxacin. Estimations of survivor fractions from CFU and MPN counts are marked here with squares and triangles. The experiments were performed independently twice in triplicates; the mean values and standard deviations are shown here: &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.005, unpaired <italic>t</italic>-test. Note the dynamic changes in the numbers of drug-tolerant survivors during prolonged incubation, as illustrated in <xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g004.tif"/>
</fig>
<p>The size of a relatively stable surviving fraction was determined from time-killing curves for the highest moxifloxacin concentration (16 MBCs, 500&#x202F;&#x03BC;g/mL) at which regrowth did not occur in all antibiotic-exposed groups (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>) and for the end of monitoring (day 14). A fraction of survived cells in the stationary-phase cultures in a complete Sauton medium accounted for 0.03% (~2&#x00B7;10<sup>4</sup>&#x202F;CFU/mL) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). As with the rest of the moxifloxacin-exposed cultures, the size of a stable surviving fraction was 10<sup>2</sup>&#x202F;CFU/mL (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3B</xref>).</p>
<p>MPN assay was useful in improving the counting of viable cells after moxifloxacin removal rather than estimating the percentage of survivors. Thus, the numbers of viable surviving cells from MPN assays ranged from 10<sup>5</sup> to 10<sup>6</sup> cells/mL (vs. 10<sup>4</sup>&#x202F;CFU/mL) for moxifloxacin-challenged mid-logarithmic cultures (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 4A,B</xref>). The MPN numbers of survivors in stationary-phase cultures, which withstood the antibiotic attack, were tenfold higher than CFU numbers (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 4C,D</xref>).</p>
</sec>
<sec id="sec18">
<label>3.6</label>
<title>Changes in the cellular integrity and morphology after short-term exposure to moxifloxacin in high concentrations</title>
<p>The slow and incomplete killing of <italic>M. abscessus</italic> during a 24-h incubation with moxifloxacin (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>) suggests significant heterogeneity within the antibiotic-exposed populations in terms of structural organization, indicating the presence of different cell types. To further investigate cell morphology and integrity, we conducted electron microscopy examinations on untreated specimens that were only washed as well as on thin sections prepared using the standard sample preparation protocol involving fixation and chemical treatments.</p>
<p>SEM examinations of unfixed and washed samples showed signs of destruction among singular or paired cells after 24-h exposure of logarithmically growing cells to the antibiotic (32.9% destructed, statistically different from the control), whereas the surface of clumped cells was intact or showed smoothing and thinning (67.1% combined), with their percentage also being statistically different from the control group (<xref ref-type="fig" rid="fig5">Figure 5</xref>, images and diagrams). Stationary-phase cells were less susceptible than mid-log cells to short-term exposure to moxifloxacin; cells with intact, destructed, and thinned-smoothened surfaces accounted for 66.4, 11.2, and 22.4%, respectively (<xref ref-type="fig" rid="fig5">Figure 5</xref>), compared to the corresponding proportions in antibiotic-challenged mid-log cultures.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>SEM images of <italic>M. abscessus</italic> cells in mid-logarithmic (upper row) and stationary-phase (bottom row) cultures grown in complete Sauton medium in the control and after exposure to moxifloxacin (500&#x202F;&#x03BC;g&#x202F;mL<sup>&#x2212;1</sup>) and incubation for 24&#x202F;h and 14&#x202F;days. Diagrams show the percentage of cells with intact (i), destructed (d), and thinned and smooth (th&#x202F;+&#x202F;sm) surfaces based on examinations of 134 to 404 cells for each set of images. Asterisks in plots for experimental groups indicate statistically significant differences (&#x002A;<italic>p</italic> &#x003C;&#x202F;0.05, &#x002A;&#x002A;<italic>p</italic> &#x003C;&#x202F;0.01) from the control group. Designations: d, destructed cells; sm, cells with smoothened surface; th, thinned surface; sh, cell shadows. Bars, 2&#x202F;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g005.tif"/>
</fig>
<p>TEM with EDX spectroscopy-based analysis of the same samples demonstrated changes in K<sup>+</sup> levels in mycobacteria treated with high doses of moxifloxacin (16 MBC) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 5</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>). Based on K<sup>+</sup> mapping for individual cells in four randomly selected fields (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 6</xref>), we could estimate the total percentage of K<sup>+</sup>-lacked cells in 24-h moxifloxacin-exposed mid-log or stationary-phase as 43.7&#x202F;&#x00B1;&#x202F;4.3%. It is important that aggregated cells in treated cultures contained K<sup>+</sup>-retaining (87.6%) and K<sup>+</sup>-free cells (12.4%), whereas 91.2% of single cells lost K<sup>+</sup> and the remaining 8.8% showed a detectable potassium level (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 6</xref>). This difference in the distribution of K<sup>+</sup>-containing cells between aggregates (clumps) and singular cells was statistically different (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). In some intact cells, there were areas of non-uniform phosphorus distribution (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 5</xref>).</p>
<p>Thin-sectioning TEM proved the presence of both dead mycobacteria with disrupted cell walls and signs of lysis and morphologically altered cells in post-stationary-phase <italic>M. abscessus</italic> populations exposed to moxifloxacin (500&#x202F;&#x03BC;g/mL, 24&#x202F;h), which were distinct from cells in the control stationary-phase cultures (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>). The presence (55.4%) of TEM images of destructed cells (a category d) and the high proportion (54%) of the cells with reduced size on the longitudinal and/or transverse sections (a category R) were statistically significantly different (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05) from the control non-treated bacteria (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In the case of stationary-phase cultures exposed to 250&#x202F;&#x03BC;g/mL of moxifloxacin for 24&#x202F;h, different cell types were observed on TEM images (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>). The significant difference from the control group was the relative abundance of cells (44.6%) with the reduced size (<xref ref-type="fig" rid="fig6">Figure 6</xref>, diagrams). Some bacteria in this group (250&#x202F;&#x03BC;g/mL of moxifloxacin, 24&#x202F;h) exhibited on the transverse sections a dense and stratified cell wall (strcw category) with an expanded electron-transparent layer between the outer mycolic acid layer and cytoplasmic membrane. Intact cells were attached to dead or destructed neighbors or embedded in vast extracellular material visible as netlike structures to be formed from released polymers or debris (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>TEM images of thin sections for the control and moxifloxacin-treated <italic>M. abscessus</italic> cultures. Cells were grown in Sauton medium broth to the stationary phase and incubated with the antibiotic (250 or 500 &#x03BC;g&#x202F;mL<sup>&#x2212;1</sup>) for 24&#x202F;h. Diagrams show the percentage of cells with more than twice the reduced length and width (R) than 1.70&#x202F;&#x00B1;&#x202F;0.36 &#x03BC;m&#x202F;&#x00D7;&#x202F;0.34 &#x00B1;&#x202F;0.07 &#x03BC;m (L&#x202F;&#x00D7;&#x202F;W) for stationary cells and the proportions of the above-designated cell types. The data were obtained by counting 106 to 379 cells in each set of images. Asterisks in plots for experimental groups indicate statistically significant differences (&#x002A;<italic>p</italic> &#x003C;&#x202F;0.05) from the control group. Designations: N, cells with size and morphology typical of stationary-phase cultures; R, reduced size; cwd, cell-wall-deficient cells; d; destructed cells; dw, dwarf cells; ex, extracellular material; str cw<sub>tr</sub>, stratified cell wall (transverse sections); ov, ovoid cells; th, thin cells; st, cells with morphology as in the stationary-phase cultures; un, unusual morphological type. Bars: 2&#x202F;&#x03BC;m (left column images); 200&#x202F;nm (the middle and right images). Enlarged images are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g006.tif"/>
</fig>
</sec>
<sec id="sec19">
<label>3.7</label>
<title>Morphology of cells in populations after prolonged exposure of stationary-phase cultures to moxifloxacin in the highest concentrations</title>
<p>SEM and TEM-EDX spectroscopy with mapping of carbon, phosphorus, sulfur, potassium, and other chemical elements proved the biocidal effect of moxifloxacin. SEM enabled the visualization of predominant &#x2018;cells&#x2019; with the destructed (d category) or thinned and smoothened (th&#x202F;+&#x202F;sm category) surface. Cells with intact surfaces were not detected in stationary-phase culture on the complete Sauton medium after long exposure (14&#x202F;days) to the highest moxifloxacin concentration (16 MBCs) (<xref ref-type="fig" rid="fig5">Figure 5</xref>, right images) upon examining more than twenty SEM fields.</p>
<p>TEM-EDX spectroscopy showed that cell remnants lost total carbon, oxygen, phosphorus, and potassium, as it is seen on colored images (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 5</xref>) or judged from the relative contents tabulated for an entire examined field with &#x2018;cells&#x2019; and surroundings (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>). The loss of these elements in individual cells can be explained by the removal of cellular components from lysed or destructed cells present in the antibiotic-challenged culture after washing biomass with water, whereas intact cells retain the intracellular constituents. A uniform distribution of total carbon on elemental maps without appearance in cell remnants (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 5</xref>, the left image in the bottom row) and reliably detectable C levels in the integral spectra for fields (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>) can be due to the presence of extracellular material that was not removed after washing used for sample preparation. However, SEM and TEM-EDX spectroscopy detected no low-abundant intact cells in such small samples (5&#x2013;10&#x202F;&#x03BC;L), and concentrating procedures with additional washing steps and supernatant removal were undesirable due to possible losses of biomaterial.</p>
<p>TEM examinations of thin sections from concentrated cultures exposed to the highest concentration of moxifloxacin for 14&#x202F;days revealed a diversity of morphological types, including (i) dwarf cells (dw) with irregular shapes (6.7% of total intact cells in the category with &#x2018;unusual&#x2019; morphology), (ii) thinned, electron-dense, cell-wall-deficient (cwd) cells (20.8%), (iii) ovoid (ov) cells (16.9%), and cells with distinct morphological features, such as stratified cell walls, compact nucleoids, and finely grained cytoplasm (<xref ref-type="fig" rid="fig7">Figure 7</xref>, images and diagrams). Additionally, we included tailed cells with thin envelopes and condensed protoplasts or bodies released upon cell wall destruction in the cwd category. The proportions of morphological types showing significant differences (<italic>p</italic> &#x003C;&#x202F;0.05) compared to the control group are presented in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Notably, cells resembling stationary-phase cells (st category) were absent. Cells with reduced size accounted for 77.7% of the total, a significantly higher percentage (<italic>p</italic> &#x003C;&#x202F;0.05) than in the control group (3%).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Thin sections of untreated stationary-phase <italic>M. abscessus</italic> cells and cells after prolonged incubation with moxifloxacin (500 &#x03BC;g/mL, 14&#x202F;days) as viewed under a transmission electron microscope. Diagrams show the percentage of cells with more than twice the reduced length and width (R) than 1.70&#x202F;&#x00B1;&#x202F;0.36 &#x03BC;m&#x202F;&#x00D7;&#x202F;0.34 &#x00B1;&#x202F;0.07 &#x03BC;m (L&#x202F;&#x00D7;&#x202F;W) for stationary cells and the proportions of the above-designated cell types. The data were obtained upon examinations of 106 cells. Asterisks in plots indicate statistically significant differences (&#x002A;<italic>p</italic> &#x003C;&#x202F;0.05) from the control group. Designations: N, cell with size and morphology as in the stationary-phase cultures; R, reduced size; cwd, cell-wall-deficient cells; d; destructed cells; dw, dwarf cells; ex, extracellular material; ol, outer mycolic acid layer; il; individual layers in cell wall; m, cytoplasmic membrane; n nucleoid; st, cells with morphology as in the stationary-phase cultures; str cw<sub>tr</sub>, stratified cell wall (transverse sections); ov, ovoid cells; th, thin cells; un, unusual morphological type. Bars: 2&#x202F;&#x03BC;m (images in the left row); 200&#x202F;nm (the middle and right images). Enlarged images are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>.</p>
</caption>
<graphic xlink:href="fmicb-15-1494147-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec20">
<label>4</label>
<title>Discussion</title>
<sec id="sec21">
<label>4.1</label>
<title>Different behavior of <italic>Mycobacterium abscessus</italic> populations under exposure to moxifloxacin</title>
<p>This study&#x2019;s novel and major result is that the fate of <italic>in vitro</italic>-cultured <italic>M. abscessus</italic> populations under prolonged exposure to moxifloxacin <italic>in vitro</italic> is pre-determined by cultivation history. As for mid-log <italic>M. abscessus</italic> cultures, the impact of potassium deficiency on prolonged moxifloxacin activity was not substantial, except for the efficient regrowth observed for populations grown in K<sup>+</sup>-depleted medium and then treated with 4&#x2013;8 MBCs of the antibiotic (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) as compared to cultures grown within the balanced Sauton medium (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The effect of the medium used was impressive for stationary-phase cultures as judged from distinct responses, depending on moxifloxacin concentrations, for cells grown in the complete medium (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and gradual diminution of an insensitive subpopulation upon exposure to all antibiotic doses (1&#x2013;16 MBCs) as for K<sup>+</sup> depletion (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). So, the imposed potassium deficiency appeared to contribute to the locking of a fraction in stationary-phase culture to be recalcitrant to moxifloxacin in a state preventing the regrowth (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Remarkably, the lack of K<sup>+</sup> in the medium prevented further rebound growth after prolonged exposure to stationary-phase <italic>M. abscessus</italic> (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) but not mid-log cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
<p>It is not simple now to explain why potassium depletion was critical for stationary-phase cells of <italic>M. abscessus</italic>. Generally, external potassium concentrations are known to influence gene expression, antimicrobial resistance, and biofilm formation in various bacterial pathogens, and potassium transport systems are crucial to fulfill nutritional and chemiosmotic requirements (see the review by <xref ref-type="bibr" rid="ref19">Do and Gries, 2021</xref>, and references therein). Potassium depletion is a severe stress factor since K<sup>+</sup> is known to be crucial for maintaining an electrochemical gradient and a proton-motive force, regulating intracellular pH and osmotic pressure in mycobacterial cells (<xref ref-type="bibr" rid="ref20">Epstein, 2003</xref>; <xref ref-type="bibr" rid="ref11">Casta&#x00F1;eda-Garc&#x00ED;a et al., 2011</xref>). Potassium deficiency caused an imbalance of energy metabolism in <italic>Mycobacterium tuberculosis</italic>, as demonstrated by transcriptomic and proteomic studies (<xref ref-type="bibr" rid="ref58">Salina et al., 2014b</xref>). The role of potassium availability in differential gene expression in active and stationary phase cells with or without K<sup>+</sup>-depletion stress remains unknown for <italic>M. abscessus</italic> and needs to be explored. The response of stationary-phase <italic>M. abscessus</italic> cultures (12&#x2013;14&#x202F;days) in K<sup>+</sup>-free medium to varying concentrations of moxifloxacin (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) was different from the behavior of moxifloxacin-challenged cells grown under the same potassium sequestration condition but stored for 24 and 44&#x202F;days, and for the aged cultures, the decline in the number of viable survivor cells (especially MPN counts of 10<sup>4</sup>&#x2013;10<sup>5</sup> cells/mL) after 14&#x202F;days of exposure to 3 MBC of moxifloxacin (<xref ref-type="bibr" rid="ref41">Mulyukin et al., 2023</xref>) was higher than in the case of stationary cultures (10<sup>2</sup> cell/mL) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 3D</xref>). It is likely that not so much stationary-phase cultures as aging post-stationary populations are reservoirs for subpopulations that can survive better in the presence of moxifloxacin. As for aging post-stationary cultures, the deepening of dormancy can be an important factor in survival in the presence of antibiotics, as discussed (<xref ref-type="bibr" rid="ref1">Ayrapetyan et al., 2018</xref>).</p>
</sec>
<sec id="sec22">
<label>4.2</label>
<title>Relation to assays of <italic>Mycobacterium abscessus</italic> &#x2018;persisters&#x2019;</title>
<p>The results of this study can inform the selection of experimental conditions, including variables such as media, time points, and antibiotic concentration, suitable for in-depth studies on persisters. <italic>M. abscessus</italic> proved to be a challenging organism for detecting the minor subpopulations responsible for prolonged survival in the presence of moxifloxacin. Conventionally and repeatedly determined MICs of moxifloxacin, which were measured at 2&#x202F;&#x03BC;g/mL (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>) and aligned with previously reported values (<xref ref-type="bibr" rid="ref21">Ferro et al., 2016</xref>), did not provide sufficient guidance for selecting a concentration range that would result in a plateau of viable cell numbers after antibiotic treatment.</p>
<p>While several MICs are typically sufficient for persister enumeration in other bacteria, such as <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="ref39">M&#x00F6;ker et al., 2010</xref>), they were inadequate for <italic>M. abscessus</italic> in our experiments (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In fact, hundreds of MICs were required, as shown in our study (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>), similar to findings in persister assays for <italic>M. tuberculosis</italic> (<xref ref-type="bibr" rid="ref55">Quigley and Lewis, 2022</xref>). The MBC of moxifloxacin for mycobacterial cultures with 5&#x02D1;10<sup>5</sup> CFU/mL, as determined in conventional assays, can be inferred from the known MBC/MIC ratios &#x2264;4 for bactericidal antimicrobials (<xref ref-type="bibr" rid="ref37">Maurer et al., 2014</xref>) and was inapplicable for cultures with high cell density (5&#x02D1;10<sup>7</sup> CFU/mL) suitable for detecting a low-abundant survivor fraction. Indeed, moxifloxacin concentrations, well higher than the MBC (<xref ref-type="fig" rid="fig4">Figure 4</xref>), were necessary to enumerate a fraction of survivors in planktonic aerated cultures, which we chose as targets for the antibiotic attack. As for the nutrient-starved and anaerobic <italic>M. abscessus</italic> cultures or biofilms, which are much less susceptible than planktonic cultures (<xref ref-type="bibr" rid="ref71">Yam et al., 2020</xref>), special conditions, suitable antibiotic concentrations, and sample preparation can be required to implement the classical assay for persister enumeration. Since the biocidal effect of moxifloxacin was gradually developing and occurred by day 3 (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>), it was important to use this time point to enumerate survivors from dose-killing curves. The larger size of survivors in the stationary phase than in preceding mid-log <italic>M. abscessus</italic> cultures (<xref ref-type="fig" rid="fig4">Figure 4</xref>) is not surprising and was quite expected from studies of the persister phenomenon (<xref ref-type="bibr" rid="ref30">Keren et al., 2004</xref>; <xref ref-type="bibr" rid="ref39">M&#x00F6;ker et al., 2010</xref>; <xref ref-type="bibr" rid="ref33">Lewis, 2007</xref>).</p>
<p>In our study, CFU counting was supplemented with the MPN assay to create conditions for the resuscitation of cells that had lost colony-forming ability. The use of resuscitation procedures for viable-but-non-cells (VBNC) cells, as reviewed by <xref ref-type="bibr" rid="ref51">Oliver (2010)</xref>, is justified since persistence and VBNC states are considered two common survival strategies for bacteria under adverse environmental conditions (<xref ref-type="bibr" rid="ref1">Ayrapetyan et al., 2018</xref>). Additionally, as reported for <italic>E. coli</italic>, these states may represent either the same dormant phenotype (<xref ref-type="bibr" rid="ref31">Kim et al., 2018</xref>) or different stages of a single dormancy program (<xref ref-type="bibr" rid="ref18">Dewachter et al., 2021</xref>).</p>
<p>Drug resistance probably contributes to the recovery of moxifloxacin-insensitive <italic>M. abscessus</italic> sub-populations after both short or prolonged exposure (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>). For an <italic>M. abscessus</italic> subpopulation in mid-log culture exposed to moxifloxacin (8 MBCs, 7&#x202F;days) and at an intermediate &#x201C;no-growth&#x201D; stage with only slight changes in CFU (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), the contribution of persisters to the pool of survivors is likely, as indicated by assays showing regrowth of surviving cells after antibiotic withdrawal under the same cultivation conditions and re-treatment with the antibiotic (subsection 3.1).</p>
<p>It should be pointed out that genetically resistant mutants capable of growing in the presence of moxifloxacin have been shown to emerge from persister subpopulations in other mycobacteria (<xref ref-type="bibr" rid="ref60">Sebastian et al., 2017</xref>; <xref ref-type="bibr" rid="ref64">Swaminath et al., 2020</xref>). Considering the varied development of small moxifloxacin-insensitive <italic>M. abscessus</italic> subpopulations that either withstand, survive, or perish under specific conditions (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>), the coexistence of genetically based resistance and persistence as a non-genetic form of antibiotic tolerance&#x2014;viewed as complementary bacterial adaptations to antibiotics (<xref ref-type="bibr" rid="ref66">Vogwill et al., 2016</xref>)&#x2014;warrants further investigation.</p>
</sec>
<sec id="sec23">
<label>4.3</label>
<title>Lessons from electron microscopy</title>
<p>Methodologically, the combined use of various electron microscopy techniques enabled us to examine cell morphology and structure (SEM and thin section TEM, <xref ref-type="fig" rid="fig5">Figures 5</xref>&#x2013;<xref ref-type="fig" rid="fig7">7</xref>) and monitor changes in the composition of biogenic elements and cationic homeostasis using non-invasive TEM coupled with EDX spectroscopy and elemental mapping (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 5&#x2013;7</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>). It may be useful to note that chemical treatment and fixatives must be avoided during sample preparation for EDX analysis, and suspensions with excessively high cell density are unsuitable.</p>
<p>To the best of our knowledge, EDX-based analysis has not been previously applied to study viable mycobacteria, but it holds promise as a valuable approach for future investigations. Notably, the electron microscopy study provided insights into the delayed biocidal effect of moxifloxacin on <italic>M. abscessus</italic>, attributed to the presence of aggregates that, unlike single cells, were destroyed only after prolonged antibiotic exposure, as evidenced by changes in cell morphology (<xref ref-type="fig" rid="fig5">Figures 5</xref>&#x2013;<xref ref-type="fig" rid="fig7">7</xref>) and monitoring of K<sup>+</sup> loss (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 6</xref>). The reduction in K<sup>+</sup> signals detected via EDX analysis (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 6</xref>) indicates disrupted homeostasis and membrane destruction, consistent with findings from previous studies on dead cells (<xref ref-type="bibr" rid="ref43">Mulyukin et al., 2002</xref>).</p>
<p>The important result from our electron microscopy study is the demonstration of the remarkable heterogeneity of <italic>M. abscessus</italic> subpopulations surviving under short or prolonged exposure to moxifloxacin. Likely, a subpopulation of survivors in the stationary phase had exploited different mechanisms of morphological transformation, which were not the same as in the case of aging antibiotic-free cultures of <italic>M. abscessus</italic> (<xref ref-type="bibr" rid="ref41">Mulyukin et al., 2023</xref>). The subpopulation that survived under a cruel moxifloxacin pressure contained various morphological types (<xref ref-type="fig" rid="fig6">Figures 6</xref>, <xref ref-type="fig" rid="fig7">7</xref>). Among them, we observed polymorphic forms resembling cell-wall-deficient (CWD) cells, well-known for mycobacteria and found in host organisms, as comprehensively reviewed by <xref ref-type="bibr" rid="ref5">Beran et al. (2006)</xref>. Some of the cells (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>) were similar to CWD cells (named L-forms) observed for ethambutol-treated <italic>M. tuberculosis</italic> and are associated with drug tolerance (<xref ref-type="bibr" rid="ref63">Slavchev et al., 2016</xref>). It is possible that the embedding in the exopolymer matrix (<xref ref-type="fig" rid="fig6">Figure 6</xref>) compensated for the lack of destructed cell walls and helped <italic>M. abscessus</italic> cells to survive. Thus, massive EPS ensured long-term survival for up to 12&#x202F;months of both antibiotic-sensitive and insensitive subpopulations of pseudomonads in the forms of normal cyst-like and cell-wall-deficient cells (<xref ref-type="bibr" rid="ref42">Mulyukin et al., 2017</xref>). Surviving <italic>M. abscessus</italic> populations contained intact cells with stratified cell walls (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>). Cells with thickened cell walls were found among antibiotic-exposed mycobacteria (<xref ref-type="bibr" rid="ref28">Jakkala and Ajitkumar, 2019</xref>; <xref ref-type="bibr" rid="ref59">Sebastian et al., 2020</xref>). Ovoid cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>) resembled in morphological traits the ovoid cells of <italic>M. tuberculosis</italic>, which were characterized as dormant forms based on a sum of their properties (<xref ref-type="bibr" rid="ref62">Shleeva et al., 2011</xref>). Some morphological types of moxifloxacin-challenged <italic>M. abscessus</italic> populations are similar to other bacteria, <italic>S. aureus</italic> (<xref ref-type="bibr" rid="ref35">Liu et al., 2024</xref>) and <italic>E. coil</italic> (<xref ref-type="bibr" rid="ref31">Kim et al., 2018</xref>).</p>
<p>It is commonly accepted and convincingly proved that the persister phenomenon is closely associated with dormancy (<xref ref-type="bibr" rid="ref50">Niu et al., 2024</xref>; <xref ref-type="bibr" rid="ref69">Wood et al., 2013</xref>; <xref ref-type="bibr" rid="ref31">Kim et al., 2018</xref>). Also, it is proposed to consider persisters from non-dormancy standpoints (<xref ref-type="bibr" rid="ref65">Umetani et al., 2021</xref>; <xref ref-type="bibr" rid="ref74">Zou et al., 2021</xref>). A consensus may be achieved because the development of a &#x2018;persister&#x2019; subpopulation under exposure to antibiotics proceeds via diverse transformation mechanisms, as was already observed for antibiotic-surviving <italic>P. aeruginosa</italic> PAO1 (<xref ref-type="bibr" rid="ref40">Mulyukin et al., 2015</xref>). Therefore, obtaining pure and enriched fractions of survived cells and characterizing them using viability tests, physiological and biochemical methods, and omics approaches is a fascinating and challenging task, although large volumes of cell cultures will unavoidably be required.</p>
</sec>
<sec id="sec24">
<label>4.4</label>
<title>Relevance for combatting <italic>Mycobacterium abscessus</italic> infections</title>
<p>Our <italic>in vitro</italic> study demonstrated that moxifloxacin, at a given concentration (e.g., several MICs or MBCs), exerts distinct effects on <italic>M. abscessus</italic> cells depending on their abundance and physiological state (<xref ref-type="fig" rid="fig1">Figures 1</xref>&#x2013;<xref ref-type="fig" rid="fig4">4</xref>). Variations in cell density and activity, the stress of potassium deficiency (<xref ref-type="bibr" rid="ref19">Do and Gries, 2021</xref>), and persisting states (<xref ref-type="bibr" rid="ref71">Yam et al., 2020</xref>) can occur in microenvironments of infected cells or tissues, influencing the phenotypic properties of <italic>M. abscessus</italic> and ultimately determining the success of antibiotic therapy (<xref ref-type="bibr" rid="ref9">Bumann, 2015</xref>).</p>
<p>Given that the response to the same antibiotic treatment may vary for mycobacterial cells likely existing in various physiological states and abundances, this could provide an additional explanation for the controversial results of moxifloxacin application against <italic>M. abscessus</italic> observed in both <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref13">Choi et al., 2012</xref>; <xref ref-type="bibr" rid="ref53">Park et al., 2008</xref>; <xref ref-type="bibr" rid="ref25">Guo et al., 2024</xref>; <xref ref-type="bibr" rid="ref48">Nie et al., 2014</xref>; <xref ref-type="bibr" rid="ref14">Daley et al., 2020</xref>; <xref ref-type="bibr" rid="ref26">Haworth et al., 2017</xref>) and <italic>in vivo</italic> studies (<xref ref-type="bibr" rid="ref49">Nie et al., 2020</xref>; <xref ref-type="bibr" rid="ref21">Ferro et al., 2016</xref>; <xref ref-type="bibr" rid="ref12">Choi et al., 2011</xref>).</p>
<p>The observed and substantial decline in the number of viable <italic>M. abscessus</italic> cells <italic>in vitro</italic> under certain conditions (i.e., K<sup>+</sup> deficiency) following prolonged exposure to moxifloxacin (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 3C,D</xref>) appears to be promising. However, the requirement for high concentrations remains a limitation for anti-persister therapy. Since prolonged treatment with high doses of conventional antibiotics is likely to be an ineffective therapeutic approach and may contribute to the development of chronic and relapsing infections, a robust anti-persister strategy is crucial for combatting severe human infections.</p>
<p>Such a strategy may involve several approaches: sensitizing persisters before antibiotic treatment, using adjuvants to enhance antibiotic efficacy, directly eradicating persisters with bioactive molecules that bypass conventional antibiotics, or preventing persister formation altogether, as extensively reviewed for various pathogenic bacteria (<xref ref-type="bibr" rid="ref73">Zhou et al., 2023</xref>; <xref ref-type="bibr" rid="ref16">Defraine et al., 2018</xref>). Notably, the membrane-active cationic glycopolymer PAAG (<xref ref-type="bibr" rid="ref44">Narayanaswamy et al., 2022</xref>) and the conjugated oligoelectrolyte COE-PNH<sub>2</sub> (<xref ref-type="bibr" rid="ref72">Zhang et al., 2024</xref>) have been shown to efficiently eradicate <italic>M. abscessus</italic> pesisters.</p>
<p>Additionally, the possibility of locking a moxifloxacin-insensitive subpopulation of survivors in a non-regrowth state, as observed in this study (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref> under specific conditions and concentrations), aligns with the proposed alternative anti-persister strategy of inducing deep dormancy (<xref ref-type="bibr" rid="ref73">Zhou et al., 2023</xref>).</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec25">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="sec26">
<title>Author contributions</title>
<p>ES: Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. BM: Investigation, Writing &#x2013; original draft. VS: Investigation, Writing &#x2013; original draft. AM: Conceptualization, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec27">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The Russian Science Foundation&#x2014;Grant 23&#x2013;15-00173 (studying <italic>M. abscessus</italic> virulence and drug-tolerant survivors) and the Russian Ministry of Science and Higher Education (studying the efficacy of antimicrobials on mycobacteria and electron microscopy) supported this study.</p>
</sec>
<ack>
<p>We are grateful to E. Kuntina, M. Sorokina, and I. Dorofeeva (Research Center of Biotechnology of the Russian Academy of Sciences) for the sample preparation and assistance conducting electron microscopy examinations.</p>
</ack>
<sec sec-type="COI-statement" id="sec28">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec29">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec30">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2024.1494147/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2024.1494147/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayrapetyan</surname> <given-names>M.</given-names></name> <name><surname>Williams</surname> <given-names>T.</given-names></name> <name><surname>Oliver</surname> <given-names>J. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Relationship between the viable but Nonculturable state and antibiotic Persister cells</article-title>. <source>J. Bacteriol.</source> <volume>200</volume>:<fpage>e00249-18</fpage>. doi: <pub-id pub-id-type="doi">10.1128/JB.00249-18</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname> <given-names>N. Q.</given-names></name> <name><surname>Helaine</surname> <given-names>S.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name> <name><surname>Ackermann</surname> <given-names>M.</given-names></name> <name><surname>Aldridge</surname> <given-names>B.</given-names></name> <name><surname>Andersson</surname> <given-names>D. I.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Definitions and guidelines for research on antibiotic persistence</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>17</volume>, <fpage>441</fpage>&#x2013;<lpage>448</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-019-0196-3</pub-id>, PMID: <pub-id pub-id-type="pmid">30980069</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname> <given-names>N. Q.</given-names></name> <name><surname>Merrin</surname> <given-names>J.</given-names></name> <name><surname>Chait</surname> <given-names>R.</given-names></name> <name><surname>Kowalik</surname> <given-names>L.</given-names></name> <name><surname>Leibler</surname> <given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Bacterial persistence as a phenotypic switch</article-title>. <source>Science</source> <volume>305</volume>, <fpage>1622</fpage>&#x2013;<lpage>1625</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1099390</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastian</surname> <given-names>S.</given-names></name> <name><surname>Veziris</surname> <given-names>N.</given-names></name> <name><surname>Roux</surname> <given-names>A. L.</given-names></name> <name><surname>Brossier</surname> <given-names>F.</given-names></name> <name><surname>Gaillard</surname> <given-names>J. L.</given-names></name> <name><surname>Jarlier</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Assessment of clarithromycin susceptibility in strains belonging to the <italic>Mycobacterium abscessus</italic> group by erm (41) and rrl sequencing</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>775</fpage>&#x2013;<lpage>781</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00861-10</pub-id>, PMID: <pub-id pub-id-type="pmid">21135185</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beran</surname> <given-names>V.</given-names></name> <name><surname>Havelkova</surname> <given-names>M.</given-names></name> <name><surname>Kaustova</surname> <given-names>J.</given-names></name> <name><surname>Dvorska</surname> <given-names>L.</given-names></name> <name><surname>Pavlik</surname> <given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Cell wall deficient forms of mycobacteria: a review</article-title>. <source>Vet. Med.</source> <volume>51</volume>, <fpage>365</fpage>&#x2013;<lpage>389</lpage>. doi: <pub-id pub-id-type="doi">10.17221/5557-VETMED</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berube</surname> <given-names>B. J.</given-names></name> <name><surname>Castro</surname> <given-names>L.</given-names></name> <name><surname>Russell</surname> <given-names>D.</given-names></name> <name><surname>Ovechkina</surname> <given-names>Y.</given-names></name> <name><surname>Parish</surname> <given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Novel screen to assess bactericidal activity of compounds against non-replicating</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>:<fpage>2417</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2018.02417</pub-id>, PMID: <pub-id pub-id-type="pmid">30364170</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bigger</surname> <given-names>J.</given-names></name></person-group> (<year>1944</year>). <article-title>Treatment of staphylococcal infections with penicillin by intermittent sterilisation</article-title>. <source>Lancet</source> <volume>244</volume>, <fpage>497</fpage>&#x2013;<lpage>500</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(00)74210-3</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname> <given-names>J. M.</given-names></name> <name><surname>Brown</surname> <given-names>K. P.</given-names></name> <name><surname>Burbaud</surname> <given-names>S.</given-names></name> <name><surname>Everall</surname> <given-names>I.</given-names></name> <name><surname>Belardinelli</surname> <given-names>J. M.</given-names></name> <name><surname>Rodriguez-Rincon</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Stepwise pathogenic evolution of <italic>Mycobacterium abscessus</italic></article-title>. <source>Science</source> <volume>372</volume>:<fpage>eabb8699</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.abb8699</pub-id>, PMID: <pub-id pub-id-type="pmid">33926925</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bumann</surname> <given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Heterogeneous host-pathogen encounters: act locally, think globally</article-title>. <source>Cell Host Microbe</source> <volume>17</volume>, <fpage>13</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2014.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">25590757</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cambau</surname> <given-names>E.</given-names></name> <name><surname>Delogu</surname> <given-names>G.</given-names></name> <name><surname>van Ingen</surname> <given-names>J.</given-names></name> <name><surname>Herrmann</surname> <given-names>J. L.</given-names></name> <name><surname>Winthrop</surname> <given-names>K.</given-names></name></person-group> (<year>2024</year>). <article-title>All you want to know about <italic>Mycobacterium abscessus</italic></article-title>. <source>Clin. Microbiol. Infect.</source> <volume>30</volume>, <fpage>709</fpage>&#x2013;<lpage>711</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2024.02.019</pub-id>, PMID: <pub-id pub-id-type="pmid">38402955</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casta&#x00F1;eda-Garc&#x00ED;a</surname> <given-names>A.</given-names></name> <name><surname>Do</surname> <given-names>T. T.</given-names></name> <name><surname>Bl&#x00E1;zquez</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in <italic>Mycobacterium smegmatis</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1489</fpage>&#x2013;<lpage>1498</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkr165</pub-id>, PMID: <pub-id pub-id-type="pmid">21613307</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>W. S.</given-names></name> <name><surname>Kim</surname> <given-names>M. J.</given-names></name> <name><surname>Park</surname> <given-names>D. W.</given-names></name> <name><surname>Son</surname> <given-names>S. W.</given-names></name> <name><surname>Yoon</surname> <given-names>Y. K.</given-names></name> <name><surname>Song</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to <italic>Mycobacterium abscessus</italic>: a prospective observational study</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>17</volume>, <fpage>1084</fpage>&#x2013;<lpage>1090</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03395.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20946409</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>G. E.</given-names></name> <name><surname>Min</surname> <given-names>K. N.</given-names></name> <name><surname>Won</surname> <given-names>C. J.</given-names></name> <name><surname>Jeon</surname> <given-names>K.</given-names></name> <name><surname>Shin</surname> <given-names>S. J.</given-names></name> <name><surname>Koh</surname> <given-names>W. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Activities of moxifloxacin in combination with macrolides against clinical isolates of <italic>Mycobacterium abscessus</italic> and <italic>Mycobacterium massiliense</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>3549</fpage>&#x2013;<lpage>3555</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00685-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22564831</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daley</surname> <given-names>C. L.</given-names></name> <name><surname>Iaccarino</surname> <given-names>J. M.</given-names></name> <name><surname>Lange</surname> <given-names>C.</given-names></name> <name><surname>Cambau</surname> <given-names>E.</given-names></name> <name><surname>Wallace</surname> <given-names>R. J.</given-names></name> <name><surname>Andrejak</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline</article-title>. <source>Eur. Respir. J.</source> <volume>56</volume>:<fpage>2000535</fpage>. doi: <pub-id pub-id-type="doi">10.1183/13993003.00535-2020</pub-id>, PMID: <pub-id pub-id-type="pmid">32636299</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Man</surname> <given-names>J. C.</given-names></name></person-group> (<year>1975</year>). <article-title>The probability of most probable numbers</article-title>. <source>J. Appl. Microbiol.</source> <volume>1</volume>, <fpage>67</fpage>&#x2013;<lpage>78</lpage>.</citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Defraine</surname> <given-names>V.</given-names></name> <name><surname>Fauvart</surname> <given-names>M.</given-names></name> <name><surname>Michiels</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics</article-title>. <source>Drug Resist. Updat.</source> <volume>38</volume>, <fpage>12</fpage>&#x2013;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2018.03.002</pub-id>, PMID: <pub-id pub-id-type="pmid">29857815</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Degiacomi</surname> <given-names>G.</given-names></name> <name><surname>Sammartino</surname> <given-names>J. C.</given-names></name> <name><surname>Chiarelli</surname> <given-names>L. R.</given-names></name> <name><surname>Riabova</surname> <given-names>O.</given-names></name> <name><surname>Makarov</surname> <given-names>V.</given-names></name> <name><surname>Pasca</surname> <given-names>M. R.</given-names></name></person-group> (<year>2019</year>). <article-title><italic>Mycobacterium abscessus</italic>, an emerging and worrisome pathogen among cystic fibrosis patients</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>:<fpage>5868</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms20235868</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dewachter</surname> <given-names>L.</given-names></name> <name><surname>Bollen</surname> <given-names>C.</given-names></name> <name><surname>Wilmaerts</surname> <given-names>D.</given-names></name> <name><surname>Louwagie</surname> <given-names>E.</given-names></name> <name><surname>Herpels</surname> <given-names>P.</given-names></name> <name><surname>Matthay</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The dynamic transition of persistence toward the viable but nonculturable state during stationary phase is driven by protein aggregation</article-title>. <source>mBio</source> <volume>12</volume>:<fpage>e0070321</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00703-21</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Do</surname> <given-names>E. A.</given-names></name> <name><surname>Gries</surname> <given-names>C. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Beyond homeostasis: potassium and pathogenesis during bacterial infections</article-title>. <source>Infect. Immun.</source> <volume>89</volume>:<fpage>e0076620</fpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00766-20</pub-id>, PMID: <pub-id pub-id-type="pmid">33875474</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname> <given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>The roles and regulation of potassium in bacteria</article-title>. <source>Prog. Nucleic Acid Res. Mol. Biol.</source> <volume>75</volume>, <fpage>293</fpage>&#x2013;<lpage>320</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0079-6603(03)75008-9</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferro</surname> <given-names>B. E.</given-names></name> <name><surname>Srivastava</surname> <given-names>S.</given-names></name> <name><surname>Deshpande</surname> <given-names>D.</given-names></name> <name><surname>Pasipanodya</surname> <given-names>J. G.</given-names></name> <name><surname>van Soolingen</surname> <given-names>D.</given-names></name> <name><surname>Mouton</surname> <given-names>J. W.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>'Moxifloxacin's limited efficacy in the hollow-Fiber model of <italic>Mycobacterium abscessus</italic> disease</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>60</volume>, <fpage>3779</fpage>&#x2013;<lpage>3785</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02821-15</pub-id>, PMID: <pub-id pub-id-type="pmid">27067317</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x00F6;berg</surname> <given-names>G.</given-names></name> <name><surname>Maurer</surname> <given-names>F. P.</given-names></name> <name><surname>Chryssanthou</surname> <given-names>E.</given-names></name> <name><surname>Fernstr&#x00F6;m</surname> <given-names>L.</given-names></name> <name><surname>Benmansour</surname> <given-names>H.</given-names></name> <name><surname>Boarbi</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Towards clinical breakpoints for non-tuberculous mycobacteria - determination of epidemiological cut off values for the <italic>Mycobacterium avium</italic> complex and <italic>Mycobacterium abscessus</italic> using broth microdilution</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>29</volume>, <fpage>758</fpage>&#x2013;<lpage>764</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2023.02.007</pub-id>, PMID: <pub-id pub-id-type="pmid">36813087</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname> <given-names>B.</given-names></name> <name><surname>Nathan</surname> <given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Targeting phenotypically tolerant <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Microbiol. Spectr.</source> <volume>5</volume>:<fpage>10.1128</fpage>. doi: <pub-id pub-id-type="doi">10.1128/microbiolspec.TBTB2-0031-2016</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greendyke</surname> <given-names>R.</given-names></name> <name><surname>Byrd</surname> <given-names>T. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Differential antibiotic susceptibility of <italic>Mycobacterium abscessus</italic> variants in biofilms and macrophages compared to that of planktonic bacteria</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>2019</fpage>&#x2013;<lpage>2026</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00986-07</pub-id>, PMID: <pub-id pub-id-type="pmid">18378709</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>W.</given-names></name> <name><surname>Shangguan</surname> <given-names>Y.</given-names></name> <name><surname>Ji</surname> <given-names>Z.</given-names></name> <name><surname>Hu</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Hu</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Clinical characteristics and antimicrobial susceptibility profiles of mycobacterium abscessus and <italic>Mycobacterium massiliense</italic> pulmonary infection</article-title>. <source>J. Glob. Antimicrob. Resist.</source> <volume>38</volume>, <fpage>83</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2024.04.004</pub-id>, PMID: <pub-id pub-id-type="pmid">38719186</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haworth</surname> <given-names>C. S.</given-names></name> <name><surname>Banks</surname> <given-names>J.</given-names></name> <name><surname>Capstick</surname> <given-names>T.</given-names></name> <name><surname>Fisher</surname> <given-names>A. J.</given-names></name> <name><surname>Gorsuch</surname> <given-names>T.</given-names></name> <name><surname>Laurenson</surname> <given-names>I. F.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)</article-title>. <source>Thorax</source> <volume>72</volume>, <fpage>1</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-210927</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hobby</surname> <given-names>G. L.</given-names></name> <name><surname>Meyer</surname> <given-names>K.</given-names></name> <name><surname>Chaffee</surname> <given-names>E.</given-names></name></person-group> (<year>1942</year>). <article-title>Observation on the mechanisms of action of penicillin</article-title>. <source>Proc. Soc. Exp. Biol. Med.</source> <volume>50</volume>, <fpage>281</fpage>&#x2013;<lpage>285</lpage>. doi: <pub-id pub-id-type="doi">10.3181/00379727-50-13773</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakkala</surname> <given-names>K.</given-names></name> <name><surname>Ajitkumar</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Hypoxic non-replicating persistent <italic>Mycobacterium tuberculosis</italic> develops thickened outer layer that helps in restricting rifampicin entry</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>:<fpage>2339</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2019.02339</pub-id>, PMID: <pub-id pub-id-type="pmid">31681204</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>M. D.</given-names></name> <name><surname>Herrmann</surname> <given-names>J. L.</given-names></name> <name><surname>Kremer</surname> <given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>Non-tuberculous mycobacteria and the rise of <italic>Mycobacterium abscessus</italic></article-title>. <source>Nat. Rev. Microbiol.</source> <volume>18</volume>, <fpage>392</fpage>&#x2013;<lpage>407</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-020-0331-1</pub-id>, PMID: <pub-id pub-id-type="pmid">32086501</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname> <given-names>I.</given-names></name> <name><surname>Kaldalu</surname> <given-names>N.</given-names></name> <name><surname>Spoering</surname> <given-names>A.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Persister cells and tolerance to antimicrobials</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>230</volume>, <fpage>13</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1097(03)00856-5</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. S.</given-names></name> <name><surname>Chowdhury</surname> <given-names>N.</given-names></name> <name><surname>Yamasaki</surname> <given-names>R.</given-names></name> <name><surname>Wood</surname> <given-names>T. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Viable but non-culturable and persistence describe the same bacterial stress state</article-title>. <source>Environ. Microbiol.</source> <volume>20</volume>, <fpage>2038</fpage>&#x2013;<lpage>2048</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1462-2920.14075</pub-id>, PMID: <pub-id pub-id-type="pmid">29457686</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lechartier</surname> <given-names>B.</given-names></name> <name><surname>Hartkoorn</surname> <given-names>R. C.</given-names></name> <name><surname>Cole</surname> <given-names>S. T.</given-names></name></person-group> (<year>2012</year>). <article-title>In vitro combination studies of benzothiazinone lead compound BTZ043 against <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>5790</fpage>&#x2013;<lpage>5793</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01476-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22926573</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Persister cells, dormancy and infectious disease</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>5</volume>, <fpage>48</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro1557</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Persister cells: molecular mechanisms related to antibiotic tolerance</article-title>. <source>Handb. Exp. Pharmacol.</source> <volume>211</volume>, <fpage>121</fpage>&#x2013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-642-28951-4_8</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Laman</surname> <given-names>P.</given-names></name> <name><surname>Jensen</surname> <given-names>S.</given-names></name> <name><surname>van der Wel</surname> <given-names>N. N.</given-names></name> <name><surname>Kramer</surname> <given-names>G.</given-names></name> <name><surname>Zaat</surname> <given-names>S. A. J.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Isolation and characterization of persisters of the pathogenic microorganism</article-title>. <source>iScience</source> <volume>27</volume>:<fpage>110002</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2024.110002</pub-id>, PMID: <pub-id pub-id-type="pmid">38868179</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luthra</surname> <given-names>S.</given-names></name> <name><surname>Rominski</surname> <given-names>A.</given-names></name> <name><surname>Sander</surname> <given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of antibiotic-target-modifying and antibiotic-modifying enzymes in <italic>Mycobacterium abscessus</italic> drug resistance</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>:<fpage>2179</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2018.02179</pub-id>, PMID: <pub-id pub-id-type="pmid">30258428</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname> <given-names>F. P.</given-names></name> <name><surname>Bruderer</surname> <given-names>V. L.</given-names></name> <name><surname>Ritter</surname> <given-names>C.</given-names></name> <name><surname>Castelberg</surname> <given-names>C.</given-names></name> <name><surname>Bloemberg</surname> <given-names>G. V.</given-names></name> <name><surname>B&#x00F6;ttger</surname> <given-names>E. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Lack of antimicrobial bactericidal activity in <italic>Mycobacterium abscessus</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>58</volume>, <fpage>3828</fpage>&#x2013;<lpage>3836</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02448-14</pub-id>, PMID: <pub-id pub-id-type="pmid">24752273</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname> <given-names>F. P.</given-names></name> <name><surname>R&#x00FC;egger</surname> <given-names>V.</given-names></name> <name><surname>Ritter</surname> <given-names>C.</given-names></name> <name><surname>Bloemberg</surname> <given-names>G. V.</given-names></name> <name><surname>B&#x00F6;ttger</surname> <given-names>E. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of <italic>Mycobacterium abscessus</italic> in the presence of inducible erm (41)</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>67</volume>, <fpage>2606</fpage>&#x2013;<lpage>2611</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dks279</pub-id>, PMID: <pub-id pub-id-type="pmid">22833642</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x00F6;ker</surname> <given-names>N.</given-names></name> <name><surname>Dean</surname> <given-names>C. R.</given-names></name> <name><surname>Tao</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Pseudomonas aeruginosa</italic> increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules</article-title>. <source>J. Bacteriol.</source> <volume>192</volume>, <fpage>1946</fpage>&#x2013;<lpage>1955</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JB.01231-09</pub-id>, PMID: <pub-id pub-id-type="pmid">20097861</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulyukin</surname> <given-names>A. L.</given-names></name> <name><surname>Kozlova</surname> <given-names>A. N.</given-names></name> <name><surname>Sorokin</surname> <given-names>V. V.</given-names></name> <name><surname>Suzina</surname> <given-names>N. E.</given-names></name> <name><surname>Cherdyntseva</surname> <given-names>T. A.</given-names></name> <name><surname>Kotova</surname> <given-names>I. B.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Surviving forms in antibiotic-treated <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Microbiology</source> <volume>84</volume>, <fpage>751</fpage>&#x2013;<lpage>763</lpage>. doi: <pub-id pub-id-type="doi">10.1134/S0026261715060077</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulyukin</surname> <given-names>A. L.</given-names></name> <name><surname>Recchia</surname> <given-names>D.</given-names></name> <name><surname>Kostrikina</surname> <given-names>N. A.</given-names></name> <name><surname>Artyukhina</surname> <given-names>M. V.</given-names></name> <name><surname>Martini</surname> <given-names>B. A.</given-names></name> <name><surname>Stamilla</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Distinct effects of moxifloxacin and bedaquiline on growing and 'Non-Culturable' <italic>Mycobacterium abscessus</italic></article-title>. <source>Microorganisms</source> <volume>11</volume>:<fpage>2690</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11112690</pub-id>, PMID: <pub-id pub-id-type="pmid">38004702</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulyukin</surname> <given-names>A. L.</given-names></name> <name><surname>Smirnova</surname> <given-names>T. A.</given-names></name> <name><surname>Shevlyagina</surname> <given-names>N. V.</given-names></name> <name><surname>Didenko</surname> <given-names>L. V.</given-names></name></person-group> (<year>2017</year>). <article-title>Long term survival and resistance of submerged pseudomonad cultures in the exopolymer mass</article-title>. <source>Microbiology</source> <volume>86</volume>, <fpage>377</fpage>&#x2013;<lpage>386</lpage>. doi: <pub-id pub-id-type="doi">10.1134/S0026261717030109</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulyukin</surname> <given-names>A. L.</given-names></name> <name><surname>Sorokin</surname> <given-names>V. V.</given-names></name> <name><surname>Vorob'eva</surname> <given-names>E. A.</given-names></name> <name><surname>Suzina</surname> <given-names>N. E.</given-names></name> <name><surname>Duda</surname> <given-names>V. I.</given-names></name> <name><surname>Gal'chenko</surname> <given-names>V. F.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Detection of microorganisms in the environment and the preliminary appraisal of their physiological state by X-ray microanalysis</article-title>. <source>Microbiology</source> <volume>71</volume>, <fpage>723</fpage>&#x2013;<lpage>734</lpage>. doi: <pub-id pub-id-type="doi">10.1023/A:1021444309796</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narayanaswamy</surname> <given-names>V. P.</given-names></name> <name><surname>Townsend</surname> <given-names>S. M.</given-names></name> <name><surname>Loughran</surname> <given-names>A. J.</given-names></name> <name><surname>Wiesmann</surname> <given-names>W.</given-names></name> <name><surname>Baker</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Polycationic Glycopolymer demonstrates activity against Persisters and biofilms of non-tuberculosis mycobacteria cystic fibrosis clinical isolates in vitro</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>:<fpage>821820</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2022.821820</pub-id>, PMID: <pub-id pub-id-type="pmid">35265060</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nessar</surname> <given-names>R.</given-names></name> <name><surname>Cambau</surname> <given-names>E.</given-names></name> <name><surname>Reyrat</surname> <given-names>J. M.</given-names></name> <name><surname>Murray</surname> <given-names>A.</given-names></name> <name><surname>Gicquel</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Mycobacterium abscessus</italic>: a new antibiotic nightmare</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>67</volume>, <fpage>810</fpage>&#x2013;<lpage>818</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkr578</pub-id>, PMID: <pub-id pub-id-type="pmid">22290346</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newson</surname> <given-names>J. P.</given-names></name> <name><surname>Gaissmaier</surname> <given-names>M. S.</given-names></name> <name><surname>McHugh</surname> <given-names>S. C.</given-names></name> <name><surname>Hardt</surname> <given-names>W. D.</given-names></name></person-group> (<year>2022</year>). <article-title>Studying antibiotic persistence in vivo using the model organism <italic>Salmonella typhimurium</italic></article-title>. <source>Curr. Opin. Microbiol.</source> <volume>70</volume>:<fpage>102224</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2022.102224</pub-id>, PMID: <pub-id pub-id-type="pmid">36335713</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>T. Q.</given-names></name> <name><surname>Heo</surname> <given-names>B. E.</given-names></name> <name><surname>Jeon</surname> <given-names>S.</given-names></name> <name><surname>Ash</surname> <given-names>A.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Moon</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Exploring antibiotic resistance mechanisms in <italic>Mycobacterium abscessus</italic> for enhanced therapeutic approaches</article-title>. <source>Front. Microbiol.</source> <volume>15</volume>:<fpage>1331508</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2024.1331508</pub-id>, PMID: <pub-id pub-id-type="pmid">38380095</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname> <given-names>W.</given-names></name> <name><surname>Duan</surname> <given-names>H.</given-names></name> <name><surname>Huang</surname> <given-names>H.</given-names></name> <name><surname>Lu</surname> <given-names>Y.</given-names></name> <name><surname>Bi</surname> <given-names>D.</given-names></name> <name><surname>Chu</surname> <given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Species identification of <italic>Mycobacterium abscessus</italic> subsp. abscessus and <italic>Mycobacterium abscessus</italic> subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics</article-title>. <source>Int. J. Infect. Dis.</source> <volume>25</volume>, <fpage>170</fpage>&#x2013;<lpage>174</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijid.2014.02.014</pub-id>, PMID: <pub-id pub-id-type="pmid">24932856</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname> <given-names>W. J.</given-names></name> <name><surname>Xie</surname> <given-names>Z. Y.</given-names></name> <name><surname>Gao</surname> <given-names>S.</given-names></name> <name><surname>Teng</surname> <given-names>T. L.</given-names></name> <name><surname>Zhou</surname> <given-names>W. Q.</given-names></name> <name><surname>Shang</surname> <given-names>Y. Y.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Efficacy of Moxifloxacin against <italic>Mycobacterium abscessus</italic> in zebrafish model in vivo</article-title>. <source>Biomed. Environ. Sci.</source> <volume>33</volume>, <fpage>350</fpage>&#x2013;<lpage>358</lpage>. doi: <pub-id pub-id-type="doi">10.3967/bes2020.047</pub-id>, PMID: <pub-id pub-id-type="pmid">32553079</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname> <given-names>H.</given-names></name> <name><surname>Gu</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Bacterial persisters: molecular mechanisms and therapeutic development</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>9</volume>:<fpage>174</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-024-01866-5</pub-id>, PMID: <pub-id pub-id-type="pmid">39013893</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname> <given-names>J. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Recent findings on the viable but nonculturable state in pathogenic bacteria</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>34</volume>, <fpage>415</fpage>&#x2013;<lpage>425</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-6976.2009.00200.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20059548</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palomino</surname> <given-names>J. C.</given-names></name> <name><surname>Martin</surname> <given-names>A.</given-names></name> <name><surname>Camacho</surname> <given-names>M.</given-names></name> <name><surname>Guerra</surname> <given-names>H.</given-names></name> <name><surname>Swings</surname> <given-names>J.</given-names></name> <name><surname>Portaels</surname> <given-names>F.</given-names></name></person-group> (<year>2002</year>). <article-title>Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>46</volume>, <fpage>2720</fpage>&#x2013;<lpage>2722</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.46.8.2720-2722.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12121966</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Park</surname> <given-names>E. M.</given-names></name> <name><surname>Kim</surname> <given-names>H.</given-names></name> <name><surname>Kwon</surname> <given-names>O. J.</given-names></name> <name><surname>Chang</surname> <given-names>C. L.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>In vitro antimicrobial susceptibility of <italic>Mycobacterium abscessus</italic> in Korea</article-title>. <source>J. Korean Med. Sci.</source> <volume>23</volume>, <fpage>49</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.3346/jkms.2008.23.1.49</pub-id>, PMID: <pub-id pub-id-type="pmid">18303198</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prammananan</surname> <given-names>T.</given-names></name> <name><surname>Sander</surname> <given-names>P.</given-names></name> <name><surname>Brown</surname> <given-names>B. A.</given-names></name> <name><surname>Frischkorn</surname> <given-names>K.</given-names></name> <name><surname>Onyi</surname> <given-names>G. O.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in <italic>Mycobacterium abscessus</italic> and <italic>Mycobacterium chelonae</italic></article-title>. <source>J. Infect. Dis.</source> <volume>177</volume>, <fpage>1573</fpage>&#x2013;<lpage>1581</lpage>. doi: <pub-id pub-id-type="doi">10.1086/515328</pub-id>, PMID: <pub-id pub-id-type="pmid">9607835</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname> <given-names>J.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Noise in a metabolic pathway leads to persister formation in <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Microbiol. Spectr.</source> <volume>10</volume>:<fpage>e0294822</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.02948-22</pub-id>, PMID: <pub-id pub-id-type="pmid">36194154</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Recchia</surname> <given-names>D.</given-names></name> <name><surname>Stelitano</surname> <given-names>G.</given-names></name> <name><surname>Stamilla</surname> <given-names>A.</given-names></name> <name><surname>Gutierrez</surname> <given-names>D. L.</given-names></name> <name><surname>Degiacomi</surname> <given-names>G.</given-names></name> <name><surname>Chiarelli</surname> <given-names>L. R.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Infections in cystic fibrosis individuals: a review on therapeutic options</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>:<fpage>4635</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24054635</pub-id>, PMID: <pub-id pub-id-type="pmid">36902066</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salina</surname> <given-names>E. G.</given-names></name> <name><surname>Ryabova</surname> <given-names>O.</given-names></name> <name><surname>Kaprelyants</surname> <given-names>A.</given-names></name> <name><surname>Makarov</surname> <given-names>V.</given-names></name></person-group> (<year>2014a</year>). <article-title>New 2-thiopyridines as potential candidates for killing both actively growing and dormant <italic>Mycobacterium tuberculosis</italic> cells</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>58</volume>, <fpage>55</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01308-13</pub-id>, PMID: <pub-id pub-id-type="pmid">24126578</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salina</surname> <given-names>E. G.</given-names></name> <name><surname>Waddell</surname> <given-names>S. J.</given-names></name> <name><surname>Hoffmann</surname> <given-names>N.</given-names></name> <name><surname>Rosenkrands</surname> <given-names>I.</given-names></name> <name><surname>Butcher</surname> <given-names>P. D.</given-names></name> <name><surname>Kaprelyants</surname> <given-names>A. S.</given-names></name></person-group> (<year>2014b</year>). <article-title>Potassium availability triggers <italic>Mycobacterium tuberculosis</italic> transition to, and resuscitation from, non-culturable (dormant) states</article-title>. <source>Open Biol.</source> <volume>4</volume>:<fpage>140106</fpage>. doi: <pub-id pub-id-type="doi">10.1098/rsob.140106</pub-id>, PMID: <pub-id pub-id-type="pmid">25320096</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebastian</surname> <given-names>J.</given-names></name> <name><surname>Nair</surname> <given-names>R. R.</given-names></name> <name><surname>Swaminath</surname> <given-names>S.</given-names></name> <name><surname>Ajitkumar</surname> <given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Cells surviving in the continued presence of bactericidal concentrations of rifampicin</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>554795</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.554795</pub-id>, PMID: <pub-id pub-id-type="pmid">33391194</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebastian</surname> <given-names>J.</given-names></name> <name><surname>Swaminath</surname> <given-names>S.</given-names></name> <name><surname>Nair</surname> <given-names>R. R.</given-names></name> <name><surname>Jakkala</surname> <given-names>K.</given-names></name> <name><surname>Pradhan</surname> <given-names>A.</given-names></name> <name><surname>Ajitkumar</surname> <given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>De novo emergence of genetically resistant mutants of <italic>Mycobacterium tuberculosis</italic> from the persistence phase cells formed against antituberculosis drugs in vitro</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>61</volume>:<fpage>e01343-16</fpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01343-16</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Lyu</surname> <given-names>Z.</given-names></name> <name><surname>Lin</surname> <given-names>Z.</given-names></name> <name><surname>Zheng</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>PhoU homologs regulate persister formation and virulence</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>865</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.00865</pub-id>, PMID: <pub-id pub-id-type="pmid">32670206</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shleeva</surname> <given-names>M. O.</given-names></name> <name><surname>Kudykina</surname> <given-names>Y. K.</given-names></name> <name><surname>Vostroknutova</surname> <given-names>G. N.</given-names></name> <name><surname>Suzina</surname> <given-names>N. E.</given-names></name> <name><surname>Mulyukin</surname> <given-names>A. L.</given-names></name> <name><surname>Kaprelyants</surname> <given-names>A. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Dormant ovoid cells of <italic>Mycobacterium tuberculosis</italic> are formed in response to gradual external acidification</article-title>. <source>Tuberculosis</source> <volume>91</volume>, <fpage>146</fpage>&#x2013;<lpage>154</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tube.2010.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">21262587</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slavchev</surname> <given-names>G.</given-names></name> <name><surname>Michailova</surname> <given-names>L.</given-names></name> <name><surname>Markova</surname> <given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>L-form transformation phenomenon in <italic>Mycobacterium tuberculosis</italic> associated with drug tolerance to ethambutol</article-title>. <source>Int J Mycobacteriol</source> <volume>5</volume>, <fpage>454</fpage>&#x2013;<lpage>459</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijmyco.2016.06.011</pub-id>, PMID: <pub-id pub-id-type="pmid">27931687</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swaminath</surname> <given-names>S.</given-names></name> <name><surname>Paul</surname> <given-names>A.</given-names></name> <name><surname>Pradhan</surname> <given-names>A.</given-names></name> <name><surname>Sebastian</surname> <given-names>J.</given-names></name> <name><surname>Nair</surname> <given-names>R. R.</given-names></name> <name><surname>Ajitkumar</surname> <given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Moxifloxacin persister cells produce high levels of hydroxyl radical, generating genetic resisters selectable not only with moxifloxacin, but also with ethambutol and isoniazid</article-title>. <source>Microbiology</source> <volume>166</volume>, <fpage>180</fpage>&#x2013;<lpage>198</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.000874</pub-id>, PMID: <pub-id pub-id-type="pmid">31746727</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umetani</surname> <given-names>M.</given-names></name> <name><surname>Fujisawa</surname> <given-names>M.</given-names></name> <name><surname>Okura</surname> <given-names>R.</given-names></name> <name><surname>Nozoe</surname> <given-names>T.</given-names></name> <name><surname>Suenaga</surname> <given-names>S.</given-names></name> <name><surname>Nakaoka</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Observation of non-dormant persister cells reveals diverse models of survival in antibiotic persistence</article-title>. <source>Bio Rxiv [Preprint]</source>. doi: <pub-id pub-id-type="doi">10.1101/2021.10.28.466227</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogwill</surname> <given-names>T.</given-names></name> <name><surname>Comfort</surname> <given-names>A. C.</given-names></name> <name><surname>Furi&#x00F3;</surname> <given-names>V.</given-names></name> <name><surname>MacLean</surname> <given-names>R. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Persistence and resistance as complementary bacterial adaptations to antibiotics</article-title>. <source>J. Evol. Biol.</source> <volume>29</volume>, <fpage>1223</fpage>&#x2013;<lpage>1233</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jeb.12864</pub-id>, PMID: <pub-id pub-id-type="pmid">26999656</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wainwright</surname> <given-names>J.</given-names></name> <name><surname>Hobbs</surname> <given-names>G.</given-names></name> <name><surname>Nakouti</surname> <given-names>I.</given-names></name></person-group> (<year>2021</year>). <article-title>Persister cells: formation, resuscitation and combative therapies</article-title>. <source>Arch. Microbiol.</source> <volume>203</volume>, <fpage>5899</fpage>&#x2013;<lpage>5906</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00203-021-02585-z</pub-id>, PMID: <pub-id pub-id-type="pmid">34739553</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weigel</surname> <given-names>W. A.</given-names></name> <name><surname>Dersch</surname> <given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Phenotypic heterogeneity: a bacterial virulence strategy</article-title>. <source>Microbes Infect.</source> <volume>20</volume>, <fpage>570</fpage>&#x2013;<lpage>577</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micinf.2018.01.008</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>T. K.</given-names></name> <name><surname>Knabel</surname> <given-names>S. J.</given-names></name> <name><surname>Kwan</surname> <given-names>B. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Bacterial persister cell formation and dormancy</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>79</volume>, <fpage>7116</fpage>&#x2013;<lpage>7121</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AEM.02636-13</pub-id>, PMID: <pub-id pub-id-type="pmid">24038684</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>M. L.</given-names></name> <name><surname>Aziz</surname> <given-names>D. B.</given-names></name> <name><surname>Dartois</surname> <given-names>V.</given-names></name> <name><surname>Dick</surname> <given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>NTM drug discovery: status, gaps and the way forward</article-title>. <source>Drug Discov. Today</source> <volume>23</volume>, <fpage>1502</fpage>&#x2013;<lpage>1519</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drudis.2018.04.001</pub-id>, PMID: <pub-id pub-id-type="pmid">29635026</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yam</surname> <given-names>Y. K.</given-names></name> <name><surname>Alvarez</surname> <given-names>N.</given-names></name> <name><surname>Go</surname> <given-names>M. L.</given-names></name> <name><surname>Dick</surname> <given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Extreme drug tolerance of <italic>Mycobacterium abscessus</italic> "Persisters"</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>359</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.00359</pub-id>, PMID: <pub-id pub-id-type="pmid">32194537</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K.</given-names></name> <name><surname>Limwongyut</surname> <given-names>J.</given-names></name> <name><surname>Moreland</surname> <given-names>A. S.</given-names></name> <name><surname>Wei</surname> <given-names>S. C. J.</given-names></name> <name><surname>Jim Jia Min</surname> <given-names>T.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>An anti-mycobacterial conjugated oligoelectrolyte effective against <italic>Mycobacterium abscessus</italic></article-title>. <source>Sci. Transl. Med.</source> <volume>16</volume>:<fpage>eadi7558</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.adi7558</pub-id>, PMID: <pub-id pub-id-type="pmid">38381846</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Liao</surname> <given-names>H.</given-names></name> <name><surname>Pei</surname> <given-names>L.</given-names></name> <name><surname>Pu</surname> <given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Combatting persister cells: the daunting task in post-antibiotics era</article-title>. <source>Cell Insight</source> <volume>2</volume>:<fpage>100104</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellin.2023.100104</pub-id>, PMID: <pub-id pub-id-type="pmid">37304393</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>J.</given-names></name> <name><surname>Peng</surname> <given-names>B.</given-names></name> <name><surname>Qu</surname> <given-names>J.</given-names></name> <name><surname>Zheng</surname> <given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Are bacterial persisters dormant cells only?</article-title> <source>Front. Microbiol.</source> <volume>12</volume>:<fpage>708580</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.708580</pub-id></citation></ref>
</ref-list>
</back>
</article>